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Patient safety research seeks to improve the delivery of care, and ensure that patients’ risk of 
injury from healthcare itself is minimised. Referral between primary healthcare, specialist 
diagnostic agencies (such as community medical laboratories and radiological centres), and 
hospital based healthcare is common and important in primary care, yet patients have highly 
variable waiting times before receiving their care. However, there is almost no research 
exploring what happens to patients while they wait. 
Aims 
This study aims to investigate patient’s waiting periods between referral from their General 
Practitioner (GP) and receiving specialist healthcare. Specifically, this study aims to determine 
if patients come to any harm in this waiting gap, and if so, which patients are harmed and what 
types of harm happen. 
Methods 
I reviewed 5 years (2003-2007) of healthcare records of 201 general practice patient’s notes. 
Each consultation record was examined to identify the types of referral that were made and to 
find evidence of harms while the patient was waiting for referred healthcare. A subset of 101 
of these patients also had the records reviewed for investigation types and evidence of harm 
while waiting for investigation.  A broad definition of harm was used to capture a greater 
number of harms. Harms were categorised as related to referral for investigation, referral to 
medical specialty or referral to other non-medical specialty. Harms were also graded in severity 
(mild, moderate and severe) and were described under the following: ‘continued symptoms’, 
‘delay in subsequent management’, ‘deterioration of condition’, ‘financial cost to patient’, 
‘anxiety/mental harm’ or ‘other’. Comparisons were made between patients whose referrals 
had evidence of harm in the waiting gap with patients who did not. Comparisons included length 
of waiting gap, age, gender and specialty referred to and used t-tests or non-parametric tests, 
as appropriate.  
Results 
5003 Consultation records were reviewed. A referral rate of 0.21 per person per year for 
medical and non-medical specialties was found, and a referral rate of 1.00 per person per year 
for investigations was found. 
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45 of 183 (25.5%) of referrals to medical or non-medical specialties had evidence of harm in the 
waiting gap, whereas 9 of 105 (1.8%) of referrals for investigation had harm in the waiting gap. 
Of the 58 total harms, 43 (74.1%) of harms were minor, 12 (20.5%) were moderate and 3 (5.2%) 
were severe. The largest broad classification of harm was “continued symptoms” with 38 harms 
(65.5%), followed by “delay in subsequent management” with 14 harms (24.1%) and 
“deterioration in condition” with 14 harms (24.1%). 
There were no statistically significant relationships between the age of patient nor sex of patient 
nor length of waiting time and the incidence of harm in the waiting gap. 
Conclusion 
This is the first study of harm in the referral waiting gap. The findings indicate that harm does 
happen while patients wait for referred care, and more research is needed to explore these 
harms. While the relatively small number of patients in this study limits the ability to draw 
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The following chapter places harms related to referral waiting times in the overall context of 
the patient safety literature. This is in order to develop aims and objectives for this study which 
will contribute to the understanding of patient harms. 
A search to find related published articles initially used various combinations of the keywords 
“referral”, “waiting time”, “waiting” and “harm” on the article databases Ovid™, PubMed™ and 
Web of Science™. However, this retuned an insufficient number of relevant results, even after 
broadening of search terms, and so a historical overview of the broader field of patient safety 
was utilised instead to define the surrounding literature. 
Since patient safety is a relatively new field this literature review will first examine the field of 
patient safety from a broad historical approach initially, and then look more specifically at safety 
in primary care and referral literature. 
1.1 History of harms research 
The concept of iatrogenic harm is possibly as old as medicine itself, with the Hippocratic Oath 
containing the directive primum non nocere: “first, do no harm”.1 However, the academic study 
of patient safety and harms is a relatively new field. This section explores the relatively brief 
history of harms research. 
Patients systemically receiving harm from the provision of investigations and treatment (or lack 
thereof) has been a known issue of health care systems at least since Barr’s article in JAMA in 
1955.2 Eventually some small studies were carried out in the United States (US) in the 1980s, 
detailing the unexpectedly high levels of iatrogenic adverse events in hospitals.3,4 But it was not 
until several larger US studies in the early nineties that the true extent of patient harms were 
known. 
The first of these studies was the Harvard Medical Practice Study in New York.5 This analysed 
over 30,000 hospital records sampled from New York hospitalisations in 1984 looking for 
adverse events present in the notes made during the 1984 admission. The researchers identified 
1,133 adverse events; a rate of iatrogenic harm of 3.7% of all hospitalisations during this period. 
This finding is supported by other large, hospital based studies from the US, Australia, the 
United Kingdom (UK) and Denmark.6-9 These show a rate (during the mid to late 90s) of harm 
due to adverse events between 3% and 16%. 
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Subsequent New Zealand studies found similar rates of adverse events in New Zealand hospitals 
of 12.9%, with a follow-up study determining that 37.1% of these were preventable.10,11 These 
studies highlight that patient safety is also a relevant issue in New Zealand hospitals, and that 
preventing a large number of harms is entirely possible. 
1.2 ‘To Err is Human’ 
Data from some of the earlier above studies regarding patient harm was published in the US 
Institute of Medicine’s seminal report To Err is Human.12 This report extrapolated from the 
studies and described medical errors that caused at least 44,000 deaths annually in the US – 
which, in the report, was then put in perspective as a greater cause of death in the US than 
motor vehicle accidents. The report went on to explore the issue of patient safety in more depth 
and made several recommendations and goals, including a 50 percent reduction in errors over 
five years. 
The Institute of Medicine makes a comparison between patient safety and the safety in other 
industries; namely Aviation and Occupational Health.12 To Err is Human notes the similarities 
between healthcare and these industries; namely, all three are complex systems, with a large 
potential for human error and all have had previously high injury and death rates.  
To Err is Human notes the safety improvements in these other industries. In aviation a 
significant improvement in safety has been accomplished, with a recent study showing a 90% 
reduction in US aviation fatalities from the 70s to today.13 
Occupational safety improvements are also similar, with rates in the US decreasing from 11 per 
100 workers in 1972 to 3.6 per 100 workers in 2009.14 The Institute of Medicine lists these 
industries’ systems approach, reporting structures (including an independent body dedicated 
to safety) and research into causes of error as key reasons for the dramatic improvement in 
safety in these industries, and that a similar approach should be applied to healthcare. 
The Institute of Medicine made several recommendations to improve patient safety within To 
Err is Human, as summarised by Donaldson: firstly, the formation of a National Centre for 
Patient Safety, secondly the formation of mandatory and voluntary reporting systems, thirdly 
involving consumer, professional and accreditation groups and organisations in improving 
patient safety and lastly for health care organisations to build a culture of safety- a workplace 
environment where safety is a top priority.15 
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1.2.1 Resulting interest in harms research  
The report To Err is Human, especially the figure of 44,000 preventable deaths annually, was 
reported widely in the media, resulting in significant concern and attention to patient safety 
throughout the US.16 This resulted in galvanising action and contributing to the US Healthcare 
Research and Quality Act of 1999.17 This Act focused resources on implementing the Institute 
of Medicine’s recommendations in order to make improvements in healthcare within the US.18 
Internationally, in 2002 the World Health Organisation (WHO) published a report on patient 
safety, which, at the fifty-fifth World health Assembly, led to a resolution that urged all member 
states to improve patient safety.19,20 In November 2003 the WHO formed the International 
Alliance for Patient Safety, a collaboration to improve patient safety globally.21 
In the decade following To Err is Human and the increased attention on patient harms, much 
has been achieved in meeting some of the Institute of Medicine’s recommendations. These 
achievements included improving awareness, formations of organisations and research.22 
1.3 Error Theory 
Both the early patient safety studies and To Err is Human focused on errors by healthcare 
professionals. While not all harms are due to errors, they contribute significantly to patient 
injury.23 Therefore, understanding and preventing harms due to errors is necessary to build 
safer healthcare systems, as noted in To Err is Human.12 
James Reason explores the theory behind error in Human Error.24 While Reason describes in 
detail the cognitive psychology model behind errors, he also describes systems in which errors 
are more likely to occur. Reason, using an approach from Perrow, describes a complex system 
with tight coupling: ‘complex’ meaning that one task or component has many effects, and 
‘tightly coupled’ meaning that one task or component is reliant upon and is strongly effected by 
one or more other components.25 Reason and Perrow describe these systems as at high risk of 
potentially disastrous errors, as a failure in one task or component can effect multiple further 
components (due to complexity), and there is little tolerance or redundancy for failure of this 
component (due to tight coupling).  
While not specifically describing patient care in Human error, Kohn et al applied this to 
healthcare in To Err is Human, analysing several cases in which error occurred and finding that 
healthcare as a system fit the description as ‘complex and tightly coupled’.12 To Err is Human 




1.4 Definitions of harms, errors and adverse events 
Until recently, there has not been a constant definition of the terms used in patient safety 
research, with the definitions differing between early studies.  
Table 1 (section 1.4.1) shows the range of definitions used in patient safety research. 
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1.4.1 Definitions between various studies  
Table 1 Definition of 'harm', 'error' and 'adverse effect' in various studies. 




2015 N/A  Physical injury, especially that 
which is deliberately inflicted 
 Material damage 
 Actual or potential ill effects 
or danger 
 A mistake 
 [mass noun] The state or 
condition of being wrong in 
conduct or judgement 
 [mass noun] technical A 
measure of the estimated 
difference between the 
observed or calculated value 
of a quantity and its true 
value. 
N/A 
Steele et al.3 1981 Iatrogenic illness on a 
general medical service at 
a university hospital. 
Iatrogenic illness: “any illness that 
resulted from a diagnostic procedure 
or from any form of therapy (excluded 
‘minor’ problems)” 
N/A N/A 
Couch et al.4 1981 The high cost of low-
frequency events: the 
anatomy and economics 
of surgical mishaps. 
N/A “A surgical misadventure resulted 
from a decision that was clearly an 
error in the field of general surgery, as 
determined by the authors and the 




1991 Incidence of adverse 
events and negligence in 
hospitalized patients: 
results of the Harvard 
Medical Practice Study I 
N/A N/A “Incidence during hospitalization of 




1995 The quality in Australian 
health care study 
N/A Preventable Adverse event: “an error 
in management due to failure to 
follow accepted practice at an 
individual or system level” 
“(1) an unintended injury or 
complication which 
(2) results in disability, death or 
prolongation of hospital 
stay, and is 
(3) caused by health care management 
rather than the patient’s disease.” 
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Reference Year Title of study Definition of harm Definition of error (or similar term) Definition of adverse event 
Thomas et 
al.6 
2000 Incidence and types of 
adverse events and 
negligent care in Utah and 
Colorado 
N/A negligence was defined as “care that 
fell below the standard expected of 
physicians in their community” 
“an injury caused by medical 
management (rather than the disease 
process) that resulted in either a 
prolonged hospital stay or disability at 
discharge” 
Davis et al.10 2002 Adverse events in New 
Zealand public hospitals I: 
occurrence and impact 
N/A Preventability (follow-up study 11) 
defined as: “Preventability of an AE 
was assessed as an error in healthcare 
management due to failure to follow 
accepted practice at an individual or 
system level.” 
“1) an unintended injury;  
2) resulting in disability; and  
3) caused by healthcare management 
rather than the underlying disease 
process. Each of these criteria had to 
be fulfilled” 
Baker et al.29 2004 The Canadian Adverse 
Events Study: the 
incidence of adverse 
events among hospital 
patients in Canada. 
 Adverse Events due to health 
management was defined as: “the 
actions of individual hospital staff as 
well as the broader systems and care 
processes and includes both acts of 
omission (failure to diagnose or treat) 
and acts of commission (incorrect 
diagnosis or treatment, or poor 
performance).” 
“an unintended injury or complication 
that results in disability at the time of 
discharge, death or prolonged 
hospital stay and that is caused by 
health care management rather than 







1.4.1.1 Comparison of definitions between studies 
As seen in Table 1, most studies did not define harm, and instead defined adverse event.4-7,10,29 
Adverse events were often defined as unintended injury occurring to a patient and resulting in 
disability. However, the injury could not be related to the disease, and usually had to be related 
to healthcare provision. The use of adverse events over harms was possibly due to a focus on 
quality improvement, as adverse effects are easier to address and to potentially prevent than 
harms – which can result at least in part from the natural progression of the patient’s illness. 
Additionally, harms have a much wider and non-specific definition than adverse events.27,28 A 
reasonable definition of harm may be reached by combining the Oxford dictionary definition 
with the various definitions of adverse events and removing some of the boundaries used in the 
definition of adverse event. One such definition may be:  
 “Harm: Physical injury, material damage, or potential ill effects that resulted from a 
diagnostic procedure or from any form of therapy.” 
While this is not a formal definition, it is very similar to the definition proposed by modern 
harms researchers (see section 1.4.3). 
1.4.2 Harms versus errors 
Following the description of harm in the early studies, interest became focused on harms due 
to errors, which were often described as a “preventable adverse event”.11 Such events were 
defined in the Quality in Australian Health Care Study as “an error in management due to failure 
to follow accepted practice at an individual or system level”.7 
To further clarify, error was defined initially by James Reason in Human Error as “a failure of a 
planned sequence of mental or physical activities to achieve its intended outcome when these 
failures cannot be attributed to chance”.24 This definition has been adopted in some newer 
patient safety research.30 
Consolidating the above definitions, adverse events differ from harms in that adverse events 
are related only to intervention or lack of intervention and not related to the disease process, 
whereas harms include all adverse events, but also include non-preventable, known negative 
consequences of treatment and all the sequelae of the initial condition. 
However, the focus on errors (over harms) in the drive for quality improvement in healthcare, 
even in To Err is Human, has subsequently tangled the difference between harm and error, with 
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harms often becoming synonymous with errors in everyday language, although, as shown 
above, this is not the case.  
Of interest, the New Zealand Accident Compensation Corporation (ACC), will pay patients and 
providers for costs related to “treatment injuries, i.e. physical injuries sustained while receiving 
treatment from registered health practitioners.” But not “personal injuries caused by illness”– 
the former would fall under the definition of an adverse event, whereas the latter would not, 
but still be considered a harm.31 
1.4.3 Current definition 
A recent paper by Runciman suggests a simplified series of definitions to be used in future 
research, including the following: 32  
 “Safety: Freedom from hazard. 
 Hazard: A circumstance or agent that can lead to harm, damage or 
loss. 
 Harm: Harm includes disease, injury, suffering, disability and death.” 
Runciman goes on to define disease, injury suffering and disability, such that harm includes all 
unpleasant experiences by patients and is thus broader than previous definitions. 
Because of the broad nature of these definitions and their subsequent integration into the 
International Classification of Patient Safety, these are the definitions that will be used in this 
thesis.33 They have been adapted and illustrated in Figure 1. 
Harm, by this definition, includes not only additional unintended or unexpected suffering, but 
also the disease process itself (defined as physiological or psychological suffering). This differs 
from previous studies in which the disease process was not included as a harm. However, this 
is justified by Runciman as closer to the colloquial use of the term ‘harm’. While this may not 
be applicable in all safety research, when discussing waiting times this broad definition was felt 
to encompass the patient experience better. 





Harm includes disease, injury, suffering, 
disability, and death  
EVENT 
Something that 
happens to or 
with a person 
CIRCUMSTANCE 
All the factors 
connected with 
or influencing an 
event, agent or 
person 
INCIDENT 
An event or circumstance that could have or did result in 
unintended or unnecessary harm to a person and/or a 
complaint/loss or damage 
AGENT 
One who, or that 
which, acts to 




































by an agent or 
circumstance 
LOSS 
Any negative consequence, 
including financial 
ADVERSE EVENT 
An incident in which harm resulted 
to a person receiving healthcare 
COMPLAINT 
An expression of 
dissatisfaction 
with something 
Figure 1 Relationship and definitions of patient safety terms - adapted from Runciman 2006.32  
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1.5 Current areas of harms research 
In the years following To Err is Human, there have been some significant advances in harms 
research and prevention, although more in some areas than others. The following are several 
key fields and examples of the progress made in patient safety and preventing harms. 
1.5.1 Anaesthetics 
Throughout the health system, individual medical specialties are beginning to tackle the issue 
of patient safety. However, anaesthesiology is regarded as at the forefront of the field, and as 
a model for other specialities to follow.34 
With studies showing high incident rates of anaesthetic mortality throughout the 1950s and 
‘60s, significant work was done to investigate and improve the practice of anaesthesiology, 
resulting in lower anaesthetic mortality rates in the 1980s and beyond.35 A US study showed a 
decrease from 2.16 deaths per 10,000 anaesthesia procedures in the 1950s and ‘60s to 0.16 per 
10,000 in the late 1970s and early ‘80s.36 While later data from the Australian and New Zealand 
College of Anaesthetists over 2009-2011 shows a rate of 1 death per 58,039 (0.17 per 10,000) 
anaesthesia procedures.37 
Work done to improve patient safety in anaesthetics includes critical incident studies 
investigating causes of anaesthetic incidents, analysis of patient risk factors and equipment 
factors.38-40 Various studies were collectively analysed by Derrington and Smith, noting specific 
areas of anaesthesia which posed a safety risk to patients and where improvements could be 
made.41 
This work and the high costs of medical indemnity lead to the formation of the Anaesthesia 
Patient Safety Foundation (APSF) in 1985, to ensure “that no patient shall be harmed by 
anaesthesia”.35 The APSF played a significant organisational role in the formation of patient 
safety in anaesthesia by encouraging further research, leading safety programmes and 
campaigns and advocating for ‘a culture of safety’.42 The APSF is noted in To Err is Human as an 
example of organisation-level approach to improving patient safety.12 
In describing anaesthesiology as a model for other specialties to follow, Gaba highlights several 
methods through which anaesthesiology has improved: the adoption of standards and 
guidelines, identification of human factors at a system level, developing patient simulation for 
research and training and, most importantly, integrating patient safety as an institution wide 
concern. However Gaba notes that there are still improvements in patient safety to be made in 
anaesthesia, since the rate of patient death due to anaesthesia is still not zero.34 
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1.5.2 Surgical checklist 
A systematic review in 2007 by de Vries et al investigated the nature of events and situations 
where hospital adverse events occurred; showing that 80.8% occurred during hospital stays and 
that the largest group (41%) of these adverse events occurred in the operating room.43 
The WHO’s World Alliance of for Patient Safety developed the surgical checklist in 2008 as part 
of the ‘Safe Surgery Saves Lives’ campaign to reduce preventable harms in hospitals, targeting 
operating theatre adverse events.44 Inspired by civil and military aviation safety checklists the 
checklist comprises of 20 checks over three stages – before anaesthesia, before incision and 
after wound closure – to break down complex tasks into simple steps and help avoid 
preventable harms.45 
An international study in 2009 which implemented a checklist (similar to the WHO surgical 
checklist) across several hospitals globally, compared 3733 surgeries before implementation of 
a checklist to 3955 after.46 The authors found a reduction of complication rate from 11.0% to 
7.0% following introduction of the checklist. Another 2010 study which followed 3760 patients 
before and 3820 after implementation of a more comprehensive checklist found a similar 
reduction in complications; from 27.3% to 10.6%.47 These studies convinced many hospitals 
globally to introduce the checklist as standard for all surgeries. 
A more recent cohort study published in 2012 by van Klei et al followed 25,513 patients 
undergoing surgery between 2007 and 2010, with the WHO surgical checklist introduced in 
2009.48 The study found a statistically significant decrease in mortality with an odds ratio of 
0.85. Additionally the authors also found that the decrease in mortality was strongly related to 
compliance with the checklist. 
These studies emphasise the approach to identifying a problem area in patient safety and how 
effective implementation of a simple safety procedure can improve patient safety. 
1.5.3 Medication harms 
Prescription of medication is the most common clinical intervention, with the Pharmaceutical 
Management Agency (PHARMAC) funding 41.8 million prescription items in 2014 in New 
Zealand.49 Yet, the use of medication also has a significant adverse event rate of 25%, with 11% 
of events being deemed preventable.50 For this reason, medication error is one of the larger 
areas or harms research. 
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Medication error is defined as “a failure in the drug treatment process that leads to, or has the 
potential to lead to, harm to the patient”.51 
Medication errors have been broadly split into two types. The first, ‘adverse drug event - ADE’ 
includes any injury from the use of a medication or drug, including anticipated side effects. An 
‘adverse drug reaction – ADR’ however is an unanticipated ‘noxious’ response to a medication 
or drug.50,51 
Systems analysis performed by Leape et al of the causes of medication errors showed that most 
medication errors are due to correctable errors within the system: physician drug knowledge, 
missing information about the patient, rule violations and others – all deemed correctable by 
improved information systems.52 
Following research to identify solutions to the problem of medication errors, a systematic 
review found that implementation of computerized physician order entry systems (or electronic 
prescribing) were effective in reducing the rate of both ADEs and potential ADEs with a relative 
risk reduction of up to 84% and 98%.53 However a recent study suggested that electronic 
prescribing facilitated new types of medication errors, and the authors suggest that electronic 
prescribing may need to be adopted cautiously.54  
1.6 Harms reporting 
To Err is Human recommended a national mandatory reporting system beginning with hospitals 
and them moving to ambulatory care for the reporting of serious harms, as well as encouraging 
the use of voluntary reporting for lesser or potential harms.12 Reporting systems were 
developed following the success of harms reporting in other industries (Section 1.2). 
Currently, the US has hospital level harm monitoring as part of the Medicare system; however 
a report by the Office of Inspector General found 86% of harms were not reported, and that 
there is no national level mandatory reporting system.55 There is no mandatory US reporting for 
error reporting in primary care, and voluntary systems vary greatly from state to state.55 
However, the FDA has a robust system for voluntary reporting of adverse drug events.56 
In the UK, The National Patient Safety Agency has established the National Reporting and 
Learning System to collect reports of patient safety incidents since 2003 - the system has since 
been incorporated into the National Health System (NHS). The National Reporting and Learning 
System has, according to Hutchinson et al, received over 1 million reports as of 2007.57 
Hutchinson et al also found that the rate of reporting has steadily increased as hospitals became 
accustomed to the system and a culture of safety developed (shown by staff surveys in 
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hospitals). However, problems have been noted with the non-mandatory nature of the 
reporting, and therefore under reporting of safety incidents especially in primary care.58 
In New Zealand, the Health and Disability Services (Safety) Act 2001 requires all serious and near 
miss adverse events to be reported by the various District Health Boards (DHBs) to the national 
Health Quality & Safety Commission, a governmental organisation.59 The definition of adverse 
event used by the Health Quality & Safety Commission is “an incident which results in harm to 
a consumer” 60 – only “serious” and “near miss” events are required to be reported, and each 
DHB uses different systems to identify these.61 
In the latest 2013-2014 report, there were a total of 454 events reported, 149% increase since 
the beginning of reporting in 2006-2007 – suggested in the report as a result of an improvement 
in DHB incident identification systems rather than an increased rate of errors.62 Patient falls 
were the greatest event reported with 248 cases. This was followed by 158 events related to 
clinical management; including delays in treatment, assessment/diagnosis and observation, as 
well as others. Events involving medications was the third largest group with 30 cases. 
Adverse events from primary care have been included from the 2013 report onwards (i.e. events 
General Practices and other primary care facilities were reported from July 2012 onwards), 
however this is not currently mandatory and in the latest report only 25 incident reports were 
from providers other than hospitals.62 
1.7 Cost of harms 
Other than physical and emotional costs of harm, some work has been done to estimate the 
financial costs of harms. To Err is Human collected several studies estimating harm before 2000, 
including the following.12 Thomas et al estimated the costs in the states of Utah and Colorado 
to be $348 million USD for adverse events, and $159 million USD (46%) of this to be from 
preventable harms. Classen et al in their study published in 1997 found an average cost of $2262 
USD per adverse drug event, and an average cost of $3,634 for serious adverse events.63 To Err 
is Human extrapolates these data to determine that, in the US, adverse events would cost 
approximately $37.6 billion USD, as they point out, greater than the healthcare cost of treating 
HIV and AIDS.12 A 2005 UK publication from the National Audit Office estimated the UK costs to 
be over £3 billion GBP total to hospitals.64 
Brown et al in a New Zealand study estimated the costs of adverse events in New Zealand 
hospitals – the authors calculated a cost of $10,264 NZD per a patient, per adverse event 
totalling $870 million NZD per year nationally.65 An Australian study by Ehsani et al calculated a 
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similar cost of $6826 AUD per adverse event, comprising 18.6% of the hospital inpatient budget 
for the hospitals sampled.66 
A review (for the NHS) by Øvretveit on potential savings, identified that there is very little 
research on the costs of harms outside of the hospital.67 There is also little evidence of the costs 
of medication errors outside of the hospital, and no costing on adverse drug events outside of 
hospitals has been performed; the only costing study found by Øvretveit was one study costing 
wasted medications at $30 USD per patient.68 
The cost of litigation is mentioned in the UK National Audit Office’s report as £423 million GBP 
for settled claims and £2 billion GBP for unsettled claims nationally.64 While there are no data 
available on litigation in New Zealand (including in primary care), a combination of ACC claims, 
as well as episodes of physician litigation for negligence, show that there is a level of financial 
cost to harms in New Zealand, although no number can currently be applied.69,70 
1.8 Primary Care and Patient harms 
The WHO conference of Alma Ata in 1978 stated that primary care is an essential approach to 
care to meet the majority of health needs of the world population.71 However, the research of 
harms in primary care is not as extensive as the research in hospitals. The US Agency for 
Healthcare Research and Quality in 2001 concluded that more research was needed in 
ambulatory care.72 A relatively recent review of harms in ambulatory care (which includes 
primary care) by the American Medical Association from 2000-2010 and found that research 
was still lacking in several key areas; including the actual incidence of harms, evaluation of 
possible interventions and the development of clear definitions.73   
The WHO, as part of their patient safety programme, recently held a meeting to discuss 
improving patient safety in primary care.74,75 They found that, again, primary care safety 
research was a priority and that the first step was more research into the epidemiology of harms 
in primary care. 
1.8.1 Structure of primary care in New Zealand 
Publicly funded healthcare in New Zealand operates under a gatekeeper model, similar to the 
NHS of the UK, and healthcare systems in Australia, Canada, Norway and Sweden.76 The model 
allows access to specialist healthcare and services that is above and beyond general practice 
care through referral from a General Practitioner (GP).77 The GP acts as a ‘gatekeeper’ who 
determines what services (if any) are required by patients and then refers them. Referral were 
usually as letters (although now electronic referral is more commonly used in New Zealand) to 
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a hospital service or department which then allocates an appointment with an individual 
consultant doctor.78 However, in comparison to other systems (notably the NHS) patients must 
pay to see a GP, although this fee is reduced after 12 visits in a year.79   
A 2009 survey of GPs from different health systems by the Commonwealth Fund found that 
New Zealand GPs reported good affordability, access and quality improvement incentives. 
However safety reporting and access to specialty care were highlighted as a concern when 
compared to other countries; with 52% of New Zealand GPs surveyed indicating safety reporting 
needs improvement and 45% indicating long waiting times to see a specialist (compared to 38% 
and 22% of UK GPs indicating the same for each respective question).76,80 
The New Zealand Ministry of Health published statistics describe 12.4 million GP consultations 
and 2.6 million nurse consultations during the 2013 calendar year, with 4.2 million New 
Zealanders being enrolled in Primary Health Organisations (94.9% of the New Zealand 
population).81 The same statistics show an average cost of $31.93 for an adult to attend a 
normal GP consultation and $15.05 to attend a low cost practice.a 
1.8.2 Likelihood for harms in primary care 
Reason’s description of error prone systems (see section 1.3) can be applied to primary care. 
While Reason did not specifically describe medical provision as such as system, he did describe 
aviation as an error prone system.24 Wilf-Miron et al point out the similarities between aviation 
and primary care – both are staffed by selected highly trained professionals, both require high 
level performance in high risk environments and both errors in aviation and errors in primary 
care may cost human lives.82  
Analysis of ACC claims show that treatment injuries do occur in primary care, with Wallis and 
Dovey showing 3845 accepted primary care claims over a four year period (2005 – 2009): 2885 
(75.0%) of these were minor claims, 701 (18.2%) were major claims, 204 (53.0%) were serious 
claims and 55 (14.3%) were sentinel claims (resulting in death or major permanent loss of 
function).69  The ACC definitions are reproduced in Table 2.  
Table 2 ACC Claim Definitions adapted from Wallis and Dovey.69 
Level of Claim ACC Definition 
Minor 
An event which results in minimal lessening of bodily function and which may require an 
increased level of care, review and evaluation, further investigation or referral to another 
clinician 
                                                          




An event which results in short-to-medium lessening of bodily function (sensory, motor, 
physiological or intellectual) unrelated to the natural course of the illness and differing from 
the expected outcome of patient management 
Serious 
An event, or related events, that has the potential to result in death or major permanent 
loss of function not related to the natural course of the claimant’s illness or underlying 
condition 
Sentinel 
An event during care or treatment that has resulted in an unanticipated death or major 
permanent loss of function not related to the natural course of the claimant’s illness or 
underlying condition, pregnancy or childbirth 
 
Comparison between primary care and hospital care showed that the proportion of minor 
claims of all claims was greater in primary care, major and sentinel claims comprised a lower 
proportion than in hospital, and serious claims were approximately the same as in hospitals. 
The most common events causing primary care treatment injury claims were firstly medication 
(37.9%), dental care (16.3%), thirdly venepuncture, cryotherapy, ear syringing combined caused 
(13.5%) and fourthly vaccination (10.2%). However 179 different types of care associated with 
treatment injuries were classified in the ACC database. While ‘delay or failure to diagnose’ was 
responsible for only 2% of claims overall, it was highly represented in serious and sentinel 
events, responsible for 15% of these. 
Gandhi and Lee, in an opinion piece published in the New England Journal of Medicine 
summarised how patient safety and harms in primary and ambulatory care are different to 
harms in hospitals.83 The authors state that treatment errors, which are more common in 
hospitals, are less common in primary care and instead diagnostic errors predominate. 
Additionally, the lack of constant medical presence that features in hospitals may lead to harms 
in primary care occurring away from the physician or other staff - never being witnessed, and 
thus unrecorded.  
Gandhi and Lee also highlight the difficulty faced with information transfer between different 
providers, especially if they have different record systems and lack face-to-face meetings. 
Finally Gandhi and Lee stress the need for a culture of safety and a leading organisation to make 
the push for safety in ambulatory and primary care – similar to the changes seen in hospital care 
but still lacking in primary care. 
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1.8.3 Harms research in general practice 
Research into harms and patient safety in primary care has advanced at a slower pace than in 
some specialities and has been identified by a WHO patient safety working group as an area of 
research priority.75,83,84 
An analysis of the literature of medical errors in primary care found four studies directly 
investigating error in primary care prior to 2002.85 
The largest of these, by Bhasale et al, collected 805 free text incident reports from a non-
random sample of 324 General Practitioners in Australia.86 Bhasale et al define an incident as 
"an unintended event, no matter how seemingly trivial or commonplace, that could have 
harmed or did harm a patient".  The demographic analysis showed that female patients aged 
>75 years and infants of both genders were over-represented in incident reports compared to 
the population attending consultations. 
In addition, following classification of the reports, Bhasale et al found a wide range of causes; 
categorised as pharmacological, non-pharmacological, diagnostic and equipment (listed in 
decreasing magnitude). Within these categories the most common specific errors were the 
prescription of an inappropriate drug (pharmacological), omission or delay of treatment (non-
pharmacological), missed diagnosis (diagnostic) and equipment malfunction (equipment). The 
authors concluded that their analysis showed that there is a larger variety of errors (and 
potential for harm) that can arise within primary care in comparison to other specialities. 
Dovey et al used 330 error reports to develop a taxonomy of errors occurring in primary care, 
splitting errors into either process (delivery) errors or knowledge (skill) errors and further 
classifying these.85 The authors classified 284 (86%) as process errors and 46 (14%) as 
knowledge errors. When analysing the reports, the reviewers found one instance of death from 
error and several where death was a potential outcome. 
The Linnaeus Collaboration (a primary care safety research group) examined 431 free text error 
reports to determine the causes of errors in primary care and possible solutions.87 The most 
common types of error were broadly “treatment process error” and “office administration 
error” (25.4 % and 18.9% respectively). The former included late referral. With regards to 
solutions, the major theme in error reports from all countries was ‘more diligence’, however 
different care and better communication were also common themes. 
Sanders and Esmail, in a literature review, found that the rate of error in primary care ranged 
from 5 - 80 per 100,000 consultations between two studies; Bhasale et al above, and an earlier 
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study based on a risk-management database by Fischer et al.86,88,89 While this rate of error is 
lower than rates found in hospital based studies (see section 1.1), with over 12 million visits to 
New Zealand GPs in 2013 alone, there is a significant scope for harm.81 
Makeham et al also used error reporting in Australia to determine the overall rate of errors 
reported in Australian primary care.90 84 GPs submitted 418 error reports over 12 months from 
490, 864 funded appointments (85 per 100,000 consultations). This gave a estimation of the 
overall rate of errors in Australian primary care. However, the authors noted that with a 
voluntary reporting system, the number of errors were possibly under reported. 
A more recent study by Singh et al examined triggers in primary care that indicated diagnostic 
errors.91 Triggers are alerts generated by automated computer systems that identify patient 
records that may contain evidence of errors. The authors examined electronic patient records 
using two triggers – firstly if a primary care consultation was followed by an unplanned 
hospitalisation, and secondly if a primary care consultation was followed by another unplanned 
consultation. With positive predictive values for a diagnostic error of 20.9% and 2.1% 
respectively, Singh et al show that diagnostic errors do occur in practice, with at least 
unintended visits or hospitalisations associated with these errors of healthcare. Additionally, 
Singh et al show that automated electronic triggers are a potential methods of identifying errors 
and perhaps, harms. However, as noted by Singh et al, further work needs to be done to refine 
triggers in order for them to be useful clinically. 
To date, the only published, large, quantitative study analysing patient records in a similar 
method to the large hospital studies (i.e. the Harvard Medical Practice Study) is a study 
conducted in the Netherlands by Gaal et al.92 Gaal et al where the records of 1000 patients were 
analysed, with reviewers analysing each set of notes for ‘patient safety incidents’, defined as: 
“an unintended event during the care process that resulted, could have resulted, or still 
might result in harm to the patient”92 
Gaal et al found 211 incidents in over 8401 patient contacts (2.2%) for 186 patients. Out of these 
211 incidents, 58 caused tangible harm, and 7 resulted in hospital admission.  
The number of incidents, and also the lack of severity of these incidents, were significantly lower 
than the rates found in hospital based studies, leading the authors to conclude that, from an 
individual patient’s point of view, primary care is relatively safe (meaning free from harm) 
compared to higher hospital based healthcare. However, Gaal et al pointed out that they still 
did find several patient safety incidents in the notes, and so there is still potential for harm to 
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occur in general practice. These authors also noted some limitations of their study; the largest 
was underreporting in the notes by healthcare professionals, and also the small number of 
practices involved in the study. Also, while not a limitation, the definition used in this study 
specifically includes only “unintended [events]”, meaning harms that result from intended 
events – i.e. where the healthcare provider was aware of the harm or potential harm – would 
not be included in their analysis. No other published study looking at rate of harms rather than 
errors in primary care could be found by the candidate, so it is assumed that the level of total 
overall harm is still unknown. 
1.9 Referral 
Referral is a process undertaken by GPs for a variety of reasons. Historically, reasons for referral 
have been indicated for diagnosis or confirmation of a diagnosis, opinion or advice of treatment, 
and/or or for treatment itself.93 Additionally an analysis of US primary care visits over 1989-
1994 showed that referral rates increased as conditions became less common, and also with 
more comorbidities; suggesting that another reason for referral is lack of familiarity with 
conditions and diseases.94 
More recent research has described physicians’ reasons for referral in a contemporary 
treatment setting. In 1998 Forrest et al studied the reasons for referral of 141 US family 
physicians who completed a questionnaire following each referral that took place over a three 
week period.95,96 Over this period, 2165 referrals (from 5.1% of visits) had questionnaires filled 
out by these family physicians (93.9% response rate). Referral was defined as “a physician’s 
decision to send the patient to see a specialist practitioner (physicians and non-physicians with 
specialised skills were included) for a face to face encounter”. This was part of a larger study 
investigating referrals from the Ambulatory Sentinel Practice Network (ASPN) – a network of 
primary care practices collaborating in safety research.97 The physician reported reasons for 
referral are reproduced in Table 3, noting that often physicians had more than one reason for 




Table 3 Reasons for referral – from Forrest et al.95 
Reason for referral 
Percentage of referrals citing 
this as a reason (%) 
Advice 
On both treatment and diagnosis  
On treatment only 






Direct surgical management 
Direct medical management 
Nonsurgical technical procedure or test 
Multidisciplinary care 






























Of note are the relatively new reasons of multidisciplinary care and patient request which were 
not mentioned in older research into reasons for referral.98 Now, as shown above, these are an 
important reason for referral, included in 13.6% of surveyed referrals, although listed as the 
sole reason in only 1.1% of referrals. 
Forrest et al investigated the characteristics of both patients and physicians involved in 34 069 
referrals from US primary care physicians.99 They found that 5.2% of visits resulted in referral. 
The only identified physician characteristics that made referral more likely was “reluctance to 
disclose uncertainty to patients”. 
Forrest et al also surveyed 796 (98% response rate) US patients who were referred by family 
physicians. The authors chose to exclude investigations (laboratory and imaging) and requests 
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for admission (via specialist or emergency department) instead focusing on outpatient 
appointments. They found that 83% of patients that were intended for referral had their referral 
completed, with 79.2% seeing a specialist. 
1.9.1 Practitioner referral rates 
As discussed, Forrest et al found a rate of 5.1% of patient visits to family practitioners result in 
referral to a specialist in their 1998 study.99 A US study by Franks and Clancy also found an 
overall rate of referral from family practitioners between 4.5% – 7% (variation depending on 
insurance scheme) of all visits.100 
A systematic review of referral variation in the UK by O’Donnell 101, showed a large variation in 
rates of referral between different studies. Following standardisation, the rates varied from 
15.4 per 1000 (1.5%) consultations and up to 191 per 1000 (19.1%) between different studies. 
While patient and clinician characteristics explain some of the difference in referral rate, after 
taking these into account, there was still a large level of variation that O’Donnell could not 
explain with the study data. 
In a different publication Forrest et al also compare the annual rate of referral in the United 
States with that of the UK.102 The authors compared the rate of referral in US health 
maintenance organisations that used a gatekeeping system with the rate of referral in the UK 
general practice database (the UK NHS utilises a gatekeeping system nationally). They found 
that 30.0% to 36.8% of patients were referred per a year from US organisations compared to 
13.9% per year in the UK NHS. This was consistent even after stratifying by morbidity scores. 
The authors postulate that lower waiting times in the US play a large role in lowering the 
threshold for physicians to refer in comparison to the UK. Additionally the authors suggest a 
more ‘intense’ practice style in the US may also play a role in higher referral rates. 
A recent 2015 Irish study also found large variation amongst Irish GPs (who are also gatekeepers 
to specialist healthcare), overall there was a mean referral rate per consultation of 11.7%, 
ranging by GP from 1% to 26%, similar to the range found in the above, earlier, systematic 
review by O’Donnell.101,103 
In New Zealand, a study published in 1991 linked general practice data with hospital data finding 
a rate of referral of 0.27 per patient per year and consultation rate of 4.3 per person per year.104 
When calculated, this showed a rate of referral per consultation of 6.7%, again fitting within the 
range of rate of referral found in overseas studies. 
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An older 1990 study reviewed a 1% of New Zealand general practice appointments in a single 
city (Hamilton) during 1979.105 They found a referral rate that varied similarly between 
practitioners in recent international studies, with an average referral rate of 7.7% of 
consultations, but ranging between 0% and 20.1%. After controlling for patient attributes, the 
statistically significant attributes that altered referral rate were ‘low consultation fees’ and 
‘non-urban practices’ (odds ratio of 0.80 and 0.79 respectively). Older GPs (aged 50+) had 1.18 
odds ratio for referral, and although not statistically significant, this suggested that, in New 
Zealand, practitioners who charge lower fees or work rurally are less likely to refer a patient and 
older practitioners are more likely to refer. In terms of patient characteristics, no results were 
statistically significant, however again odds ratios of 0.81 for patients in the 65+ age group and 
0.78 for those of Māori ethnicity suggest that these groups may be referred less – perhaps 
suggesting a disparity between these groups.  
Also in New Zealand, Nixon et al investigated the use of computerised tomography (CT) in the 
Otago Southland region, noting that when a new scanner was made available, referral for CT in 
that region increased by 119%, suggesting that availability of services may also be a factor 
behind variation in referral rates between regions and/or practices.106 
1.9.2 Referral process in New Zealand 
Access to specialist care in New Zealand is through a ‘gatekeeper’ system similar to the UK’s 
NHS (rather than a generally open access system in the US), where a GP first assess patients and 
then determines if they require referral, and which specialty to refer to.107 Gatekeeping is 
implemented to save costs, as primary care is considered a cheaper setting to provide care in 
than in hospital (partly because of the patient co-payment system in New Zealand general 
practice which does not apply to hospital care) and also to improve matching of patients to the 
correct speciality.108-110 
However, the cost-benefit of a gatekeeper system is currently not scientifically established as 
in the long run gatekeeping may cause hospitals to become over specialised, according to 
Brekke et al.109 These authors hypothesise that gatekeeping drives specialists away from 
generalist training and general skills, and instead focuses on specialization to increase 
differentiation between clinicians and between hospitals. This increases competition and 
profits, but may reduce the overall quality of healthcare provision in each hospital due to 
becoming less generalised and more inefficient in the long run. 
Between 1996 and 2000, the New Zealand health system replaced the traditional waiting lists 
for referred care with a booking system that prioritises patients according to clinical priority 
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assessment criteria (or CPAC) scores to indicate greatest patient need and patients who can 
benefit most from referred care. CPAC criteria were determined by clinicians and health 
economists. The intention was to enable more efficient use of limited health resources and to 
enable those patients who were worse off to be treated first.111,112 
1.9.3 New Zealand referral patterns 
No recent data are available for number of referrals in New Zealand, however with 12.4 million 
GP visits annually, and an assumed rate of referral between 1% and 20%, it can be estimated 
that there would be between 124,000 to 248,000 referrals every year in New Zealand.81 With 
regards to waiting times, the Ministry of Health as of January 2015 specifies a target waiting 
time of less than 4 months and although this is not always met, over the Jan 2015 to May 2015 
period, between 95.2% and 100% of patients were seen within this target (the data is reported 
per month, stratified by DHB).113 
Dovey et al surveyed 200 random New Zealand GPs about 33 conditions and how likely they 
would be to refer.114 The authors found a high degree of consensus between practitioners 
amongst all 33 cases. Several conditions were reported as seldom or never needing referral 
including hypertension, hypothyroidism, rheumatoid arthritis not requiring second line therapy 
and obesity, highlighting that there were many conditions that GPs felt comfortable managing 
in primary care without referral. However there were several conditions where almost all 
(>82.9%) of GPs would always refer – post menopausal bleeding, rheumatoid arthritis requiring 
second line therapy, multiple sclerosis, insulin dependent diabetes and patients with altered 
bowl habit with rectal bleeding. The high degree of consensus amongst these conditions on 
either end of the referral spectrum show that for certain conditions, referral (or non-referral) 
in New Zealand is likely to be the same regardless of GP. However, the survey results indicated 
many ‘sometimes refer’ conditions; including mental confusion in the elderly, indigestion and 
dyspepsia, feeding problem in infancy, and problems in relationships: while the majority of GPs 
indicated ‘sometimes’ (i.e. still a high degree of consensus), this shows that many conditions 
depend on the presentation and interpretation by the GP – signalling possible reasons for very 
different rates of referral between GPs. This would fit with the international data which shows 
a wide variation in referral rates. 
Additionally, as mentioned above, while Dovey et al looked at referral patterns for a series of 
conditions in 1993, and Davis reviewed data from 1979, no more recent data on overall referral 
patterns are available in New Zealand. However, public hospitalisation data is available for 
diagnosis upon discharge.115 While this does not detail the numbers cared for by each specialty, 
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it does describe broadly the conditions New Zealanders are hospitalised for, and give an 
indication which services are in demand. Figure 2 displays the proportion a group of diagnoses 
of the total discharges over the 1st July 2012 to 30th June 2013. The largest category, “factors 
influencing health status and contact with health services” describes patients admitted for 

























Factors influencing health status and contact with health services
Injury, poisoning and certain other consequences of external causes
Symptoms, signs and abnormal clinical and laboratory findings
Pregnancy, childbirth and the puerperium
Diseases of the digestive system
Diseases of the circulatory system
Diseases of the respiratory system
Neoplasms
Diseases of the musculoskeletal system and connective tissue
Diseases of the genitourinary system
Certain infectious and parasitic diseases
Diseases of the nervous system
Diseases of the skin and subcutaneous tissue
Mental and behavioural diseases
Diseases of the eye and adnexa
Endocrine, nutritional and metabolic diseases
Certain conditions originating in the perinatal period
Diseases of the blood and blood related organs
Diseases of the ear and mastoid process
Congenital malformations, deformations and chromosomal abnormalities












Hospital discharges by diagnosis group
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1.9.4 International and New Zealand waiting times 
Several studies measuring waiting times have been conducted internationally. A 2013 Canadian 
study by Thanh et al examined waiting times (the time from referral by a family physician to an 
appointment date) by specialty over 2009, 2010 and 2011.116 The authors examined 33,281 
referrals from family physicians and found an average waiting time of 86 days, although the 
average waiting time decreased over each subsequent year of the study. The overall rate varied 
greatly by specialty. For example, ophthalmology had an average waiting time of 54 days and 
neurosurgery an average of 146 days. The most common demographic of referred patients was 
female and between 19-64 years. The mean overall waiting time by speciality is adapted in 
Figure 3, shown in green shaded bars. 
Part of an OECD report in 2003 described outpatient waiting times (time between referral from 
a GP to a specialist appointment) for only elective surgery, excluding non-surgical referrals.117 
Data were available from England (2001), Denmark (2000) and Norway (2001) (the latter two 
were estimated). Only the data from England were analysed by speciality, and is adapted in 






























Waiting times by specilaty
Canada - from Than et al England - from Siciliani & Hurst (OECD)
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Kelly et al investigated patient satisfaction in outpatient facilities in the US. Although they were 
investigating wait times in waiting rooms (an average of 22 minutes for treatment 
appointments) rather than days between referral and receipt of care, the authors found that 
average patient satisfaction scores was influenced strongly by waiting times – from a total score 
of 90.6 for 0-5 minutes to 51.1 for more than 20 minutes.118 While this is not directly applicable 
to waiting times for referral, it does give some evidence that patient are dissatisfied with longer 
waits, and that this may negatively affect their entire healthcare experience. 
New Zealand data on waiting times, while recently collected by DHBs for the Ministry of Health, 
had not yet been collated and published at the time of writing this thesis. There are plans in the 
future for these data to be published as part of a new data collection the National Patient Flow, 
but it is not currently available for analysis.119    
However, the New Zealand Ministry of Health does publish data on the regional DHBs’ 
achievement of first specialist assessment targets. The Ministry defines an acceptable waiting 
time as less than 4 months. In their May 2015 publication all DHBs had <1% of patients waiting 
longer than four months.113 No further details were available from the Ministry. 
1.9.5 Media attention on referrals 
While there is little published epidemiological data about harms during referral waiting periods, 
local and national media have published individual anecdotal accounts of patients suffering 
while waiting. New Zealand local newspapers have published articles about patients on ‘waiting 
lists’ and discussing their waiting time lengths – both in terms of number of patients and time 
spent waiting.120-122 
Much attention has been made of surgical waiting lists. Numerous articles detail individual cases 
of patients who have been waiting a long time and personal stories of emotional and physical 
difficulties while waiting for surgery.123-125 One recent article described the experience of a 
patient as he waited for a specialist appointment regarding bariatric surgery, including his 
difficulty with daily living (showering and mobilising) and anxiety about if he was to receive 
surgery in the future.126 
From a healthcare provider perspective, a 2003 article in the NZ Doctor  (a monthly publication 
for medical professionals in general practice) highlighted issues with GPs having to manage the 
care of patients who would not be seen by specialty services, as they did not meet criteria for 
appointments in the public hospital system.127 Following referral from GPs, due to limited 
resources, hospitals re-referred these patients back to GPs to manage patients’ symptoms, with 
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the advice to refer them to the hospital again if their condition was to worsen. The article 
highlights GPs’ frustration and difficulty in having to manage symptoms for which there is a 
known treatment, but has been denied to patients by administrative funding decisions.  
Media accounts of individuals suffering harm waiting, while not definitive, do suggest that there 
may be a wider problem in the healthcare system that requires further scientific study. 
1.9.6 Potential of harms to arise from the referral process 
The Institute of Medicine’s follow up to To Err is Human was Crossing the Quality Chasm, which 
discusses methods to improve healthcare quality.128 One of the six aims is related to timeliness 
of care. The authors suggest that long waiting times signal poor organisation and a lack of 
patient catered care. 
New Zealand research by Derrett with patients waiting for prostectomy and hip joint 
replacement showed no relationship between CPAC scores and patient experience of need and 
symptoms.129 Derrett interviewed 149 patients, finding that all had some symptoms – at least 
mild pain in the hip replacement group, and ‘bother’ (at least one urinary symptom) in the 
prostectomy group. 
While Derrett focused on surgical waiting periods for two specific surgeries, and so the findings 
are not applicable to all patients waiting for referral or treatment, this study shows that while 
waiting, patients experience negative symptoms, (or harms) which may have been prevented 
by patients being treated earlier (i.e. a shorter waiting period). 
1.9.7 Referrals and patient anxiety 
A qualitative study by Preston et al in Leicester, UK interviewed 33 patients about their 
experience of the interface between primary and secondary care.130 Participants were selected 
randomly from hospital discharges, outpatient appointment lists and from GP referrals – 
meaning not all participants had experience of referral waiting periods. When speaking of 
referral waiting, participants felt that referrals for chronic health problems or stigmatising 
conditions were often delayed, causing them to feel their problems were less legitimate or real. 
On the other hand, participants reportedly had more confidence with their referral if they had 
a good doctor-patient relationship with their GP. Participants often expressed intense relief at 
‘getting in’ when their referral was accepted, and receiving an appointment, implying, that 
during the waiting period patients were under some level of emotional stress, although this was 
not specifically expanded upon by the authors. 
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The participants also described a common experience of ‘limbo’, which the authors described 
as a state in which patients feel as if they are not making any progress – including periods of 
indefinite waiting, uncertainty, and feelings of unimportance and insignificance. This occurred 
mostly as participants moved through the interface between primary care and hospital level 
care, or vice versa. Additionally, participants’ experiences were worse when the waiting times 
were unknown or when the waiting time seemed disproportionate to the urgency of their 
problem. 
While the sample by Preston et al was limited to 33 United Kingdom patients, their experiences 
show that there is some emotional harm related to referral that may be almost unavoidable. 
The similarity of the UK ‘gatekeeper’ system to New Zealand’s system strongly suggests that the 
same might occur here. 
1.10 Laboratory tests 
Modern medicine is relying more and more on the use of laboratory investigations to aid, 
confirm and rule out diagnosis and monitor existing conditions. Laboratory tests include blood 
tests and microbiology services.131 
Using the definition of referral as “a physician’s decision to send the patient to see a specialist 
practitioner (physicians and non-physicians with specialised skills were included) for a face to 
face encounter”, as used by Forrest et al above, laboratory tests may not always count as a 
traditional referral. On the other hand, GPs are requesting an investigatory service with possibly 
additional opinion or interpretation of the results, and there is a waiting time where harm could 
foreseeably occur (a ‘referral waiting gap’). In this study the candidate considered laboratory 
requests as a potentially different type of referral, and within the scope of ‘harms in the waiting 
gap’.  This section gives a brief overview of laboratory services and related harm. 
1.10.1 Rate of Laboratory tests 
A collaborative European study selected 340 GPs from several European countries (Belgium, 
Ireland, Italy, the Netherlands, Portugal, Spain, Switzerland and the United Kingdom).132 Over 
the study period, there were 156,021 patient contacts resulting in 37,772 blood tests, (i.e. 24.2% 
of consultations involved a blood test). Overall 7.7% of patients had one or more blood tests 
over the observation period, although this varied greatly by country, from 5.1% in the UK to 
13.1% in Switzerland. Females aged 25-64 years had the most blood tests (except in Switzerland 
where Females 65-74 had more), and the least blood tests were for males aged 0-4 years. The 
analysis of several factors explained 49% of the variation between practitioners, of those, the 
31 
 
largest contributor was the country of practice, although 15% of variation was due to practice 
characteristics including distance to hospitals. These results suggest that to a degree laboratory 
testing is culturally determined and also that that GPs are less likely to order a blood test if it is 
less convenient for the patient (further away from the practice).  The large variation between 
GPs even after standardisation also suggests that some GPs are overusing blood tests (assuming 
that those using less tests are still practising safely). 
Labtest New Zealand, which supplies Auckland with laboratory services states on their website 
that they perform over 200,000 tests per a week for the Auckland population of approximately 
1.4 million people.133,134 Unfortunately, this statistic includes hospital tests, and no information 
on tests in New Zealand general practices was found by the candidate.  
1.10.2 Harms related to blood tests 
It is a recently recognised aspect of patient safety that the overuse of investigatory and 
diagnostic laboratory procedures can be harmful to patients. Several studies have shown harm 
related to investigations. Specifically in primary care, the lack of follow up for investigations, as 
well as the lack of informing patients of blood test results, both result in harm.135-138 Additionally 
there is the potential for physical harm from the procedure itself, including nerve injury, 
infection, haematoma and needle-stick injuries to healthcare workers.139-141 
A review by Callen et al of studies on failure to follow up test results showed a large variation, 
from 6.8% of tests, where computerised pop-ups were used, to 62% in a different practice 
without computerised records.142 Additionally the impact to patients reported in some studies 
in the review included missed cancer diagnoses, hospital visits for raised blood potassium, and 
under-supplementation of thyroid hormone resulting in adverse drug events. Additionally, in 
one study, diabetics whose results were checked were more likely to receive follow-up 
appointments than those whose tests were not.143 
Hickner et al collected reports from primary care professionals of errors related to testing 
process (including lab tests, diagnostic imaging and other tests).144 Over 32 weeks 661 events 
were reported by 243 participants. This varied by practice from 25.87 to 1.5 reports per 
participant per practice. Of the patients involved, 64% were female, and 70% were aged 18-64 
years, similar to the demographics of patients having blood tests, as above.132 The major types 
of errors were ‘reporting to clinicians’ (24.6%), implementing tests (17.9%), availability of results 
(17.6%) and test ordering (12.9%). Errors related to responding to tests made up 7% of reports. 
Patient harm was reported in 18% of all reports, and of these, temporary physical harm 
occurred in 69 cases (11% of total reports), and emotional harm in 33 (6%). Permanent harm 
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was reported in 3 cases (0.5%) and there was 1 case of temporary harm that required 
hospitalisation. The research showed the types of harm that result from investigation and the 
management thereof, and that some of these are ‘serious’. 
The increased amount of information offered to GPs without systems to manage and distribute 
this information is leading to what has been described by Beasley et al as ‘information chaos’ 
due to both too much information (overload) and missing important information (under-
load).145 The authors describe how this leads to difficulty in making decisions, and increased risk 
for decision errors, which (as described in section 1.3) could result in patient harm. 
Elder, in a recent editorial, highlighted the fact that laboratory tests are still a problematic area 
in primary care safety and a risk to patients.146 However Elder states that advances in 
information technology which involve patients with their laboratory results hold promise in 
making the process safer and more beneficial for patients.  
1.11 Summary of the literature review 
Harms related to referral, both to specialties and to laboratories is an under-researched field. 
What research there is shows the importance of referral (section 1.9) but also varied rate of 
referral between practitioners (sections 1.9.1 and 1.10.1). Waiting times for referral are also 
highly variable, and likely to vary between the health systems of different countries (section 
1.9.4). Additionally, the referral process also generates a level of patient anxiety, (section 1.9.7) 
and during the referral process there is an opportunity for harm (section 1.9.6). How much harm 
however, especially in New Zealand, is currently unknown. 
1.12 Aims generated from the literature review 
Following a review of the literature, a gap in current harms research emerged regarding harms 
to patients while waiting for hospital specialist cares and investigations. While waiting time 
variability as well as potential for harm was identified in the literature, no study found by the 
candidate during the literature review identifies nor details harms during the referral waiting 
period.  
The aim of this study is to address this gap in the literature by investigating patient’s waiting 
periods between referral from their General Practitioner (GP) and receiving specialist 
healthcare or investigation responses. This study’s objectives are to determine if patients in the 
study sample come to any harm in this waiting gap, and if so, the rate of this harm, which 
patients are harmed, what types of harm happen and if these harms are preventable. As this is 
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the first known study of harms during referral waiting gaps, this study aims to be a preliminary 




2.1 Data collection  
2.1.1 Extraction for the HRC Safety in general practices feasibility study 
In 2006, 36 practices from an existing research network were recruited into a feasibility study 
designed to establish the design of a full study of the epidemiology of harm in general practice 
(see Appendix B). These practices provided all their patient notes to analyse. The notes covered 
a period from 2003 to 2007.  Notes from a random selection of 2400 patients were extracted 
into a database file. The patient names and other identifiers such as NHI codes were not 
extracted into the database file in order to anonymise the data. For study purposes each patient 
file was assigned a number beginning from 1, up to the last patient (2400). Additionally, each 
practice and each provider (GPs and nurses) were assigned a unique identifying number also 
used in the database.  
The data extracted included: the sex of the patient, the date of each entry, the date each 
component of the health record was made, the type of entry (see below), and the data from 
this entry. A description of the data extracted is provided in Table 4. 
While these data were subsequently used in the feasibility study, the data used for the current 
project were in the unaltered and preserved file produced by the extraction process. However 
the original database of patient records was unavailable for confidentiality reasons, so repeat 
extraction or confirmation of data (e.g. clinic letters) was not possible.  
Additional information such as clinic letters from outpatient appointments and non-text 
investigation results (imaging, ECG etc.) were not included in the extracted data, due to an 
inability to anonymise this information. However, this information was often included in a 
consultation note by the practitioner. 
In the event of uncertainty over the referral dates, this was marked in the data table (See 
Section 2.3 and Appendix B). 
2.2 Sample selection 
As the patient numbers assigned to the notes were already randomly assigned, the sample was 
selected in ascending numerical order; from 1 to 100. This was not strictly random in this study, 
however as the patients were randomly ordered in the original database, this was deemed 
appropriate. Additionally, a randomly selected set of notes (patient number 2016) was 
randomly selected to test the coding system initially, and remained in the study. 
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A sample size was not established in advance, as the expected level of harm was unknown as 
well as the expected level of referral was also unknown. It was decided that the as many records 
as possible would be analysed within the limitations of the project timeframe. A number of 101 
notes was selected, and following preliminary analysis of the results, the study group size was 
expanded to 201. This was due to the high number of investigation data in the first selection of 
notes, and the time consuming nature of recording the data. In order to collect more non-
investigation referral data in the study timeframe, the second study group did not have 
investigation data collected by the candidate, although it was present in extracted record. 
This is shown in Figure 4. 
Table 4 Description of Data fields 
Type of data Data included in this field 
Consultation The electronic notes written by the practitioner.a  
Read code 
 
Any diagnoses ‘coded’ to this patient – Read codes for current 
diagnoses. 
Measurement/Screening 
Electronic entry for patient characteristic to be tracked by the 
provider – including weight, blood pressure etc. Can also 
include measurements/ investigations taken at the practice 
(including urine dipstick). 
Vaccination Record of vaccination by practitioner. 
Hospital admission 
The automatic discharge summary of the patient. Dates of 
admission and dates of discharge, diagnoses and procedures 
carried out during admission are included in these entries. 
Lab test 
Includes all investigations, blood tests, microbiology, radiology 
and other.   
Dates on these entries were usually from when the lab 
received the test request. However some notes contained 
additional entries when results were reported. 
Prescription Electronic prescriptions made by the practitioner. 
 
                                                          
a Due to the data extraction process, these entries were unintentionally truncated at 256 characters. 
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2.3 Analysing the notes 
Each set of patient notes was read in order of patient ID – this was randomly assigned during 
the extraction process. The notes themselves were read in a chronological order, with reading 
the consultation note first to give context to other entries occurring on the same and following 
date. 
Each consultation note was examined for evidence of referral following a presentation; often 
written as “refer to”, or “plan: ref to” or “to see” or “letter to” as well as others. When a referral 
was found in the notes, the date (or approximate date if this was uncertain) was recorded. The 
service referred to was also recorded. In addition other details unique to the referral were 
entered into a freeform ‘notes’ field, in order to give context to the referral for review of the 
data at a later period. 
Referrals services were classified by the following categories of speciality services, modified 
from a recent Canadian referral study by Thanh et al.116 Radiology was added as a category, as 
in New Zealand, a radiology referral is required for some imaging studies. “Specialty clinics” was 
removed from Thanh’s list as a category, due to it being inapplicable as a category for this study 
in New Zealand. The final modified specialty list is presented in Table 5. 
Following a consultation which resulted in a referral, all entries present in the notes following 
the referral date and up to the conclusion of the referral (i.e. the patient being seen by the 
referred service) were read, and checked to see if they contained any indication of harm. This 
involved closely reading each consultation entry and identifying any evidence of harm. Harm 
was defined as “including disease, injury, suffering, disability and death” as described in section 
1.4.3 and Figure 1. The result (harm present or not) was then recorded in a new data table 
constructed for the current research. An excerpt of this data table is available in Appendix B. 
Reading the consultation records was often difficult, with notes often using idiosyncratic 
shorthand to the particular practitioner. In addition truncation of the notes at 256 characters 
may have excluded important information at the end (including referral plans). In the event of 
truncations, and a following entry about a referral result, the context of the consultation would 
often allow the researcher to determine that the referral would have occurred during the 





























Table 5 List of Specialty services 
Specialty 









Obstetrics and Gynaecology 
Ophthalmology 
Orthopaedics 
Ear Nose Throat / ENT 
Paediatrics 
Physical Medicine and Rehab 
Plastics 








2.3.1 Classifying Harms 
When a harm was found, the following data were recorded in the data table. The severity of the 
harm (mild, moderate, or severe) and the type of harm. Notes about each episode of harm were 
also written in the freeform field. 
Severity was defined as in Table 6. 
39 
 
Table 6 Definition of severity classification 
Severity Definition 
Mild 
Causing temporary loss, disability or suffering 
that resulted in little to no impairment. 
Moderate 
Causing temporary or permanent loss, 
disability and/or suffering that resulted in 
some loss of function and/or impairing daily 
activities to some degree. 
Severe 
Causing temporary or permanent loss, 
disability or suffering that resulted in 
significant loss of function, and/or preventing 
daily activities completely, or death. 
 
These definitions were developed for this study, modelled on the definitions of harm, loss, 
suffering and disability proposed by Runciman as well as severity definitions used by the 
ACC.32,69 These definitions do have a level of overlap between mild to moderate and moderate 
to severe, and so a case may fall into either category due to the lack of specifics in the definition. 
Where overlap occurred the candidate chose the higher of the two overlapping severity codes 
as a rule, so not to underestimate and minimise harms.   
Harms were described and coded using a modified newly developed coding system developed 
by Dovey and Leitch for the currently in progress ‘Patient harms in New Zealand general 
practices: Records review study’. As all harms were related to referral, only the cause of harm 
coding axis and the subjective patient experience sections was applicable to this study. The 
coding system is reproduced in Appendix B.  
Following final coding of all harms it was found that there was a large range of codes used. 
Therefore, harms were additionally coded into several broad categories for ease of analysis. 
These broad codes were developed uniquely for this study following initial data collection. This 
was done by grouping initial codes (as above) and their sub codes and grouping other harms by 
analysing the free form note fields written during data collection (see excerpt of data table in 
Appendix 2). Note that an individual harm related to referral could be classified with multiple 




Table 7 Definitions of broad harm categories 
Broad Category of harm Definition 
Continued symptoms 
The symptoms with which the patient presented 
with continued throughout or at some point during 
the referral waiting period, requiring a visit to the 
GP and/or continued treatment. 
Delay in subsequent management 
Management or treatment was delayed due to 
waiting for referral (i.e. due to waiting, the patient 
did not have the appropriate next step in 
management). 
Deterioration of condition 
Additional development of worse or subsequent 
symptoms or increased impairment or increased 
suffering. 
Financial cost to patient 
Any event documented in the notes related to 
waiting that cost the patient in time or money or 
both. 
Anxiety/Mental harm 
Any mental stress or harm that arose from waiting 
or as a result of the patient’s condition during the 
waiting gap. 
Other 
Any other harms that did not fit into the above 
categories (these were recorded as freeform fields, 
and are presented in the results section). 
 
While these above definitions are broad, the harm must have been recorded in the consultation 
notes in order to be classified as such. 
Additionally, for unclear episodes of harm this was recorded as ‘query harm’ (a ‘?’ in the table). 
These uncertain harms were reviewed with the project supervisor (Professor Susan Dovey) to 
determine if they were a harm and if so, what severity. Following this these entries were 




2.4 Data collection for blood tests and other laboratory investigations 
Data about blood tests and other laboratory investigations were collected for the first 101 
patients. These were classified as shown in Table 8, using a simplified grouping of tests for ease 
of analysis. 
Table 8 Definition of Investigation types 
Investigation classification Description 
Blood test All tests ordered involving the collection of 
patient’s blood by either a separate 
laboratory service or blood collected at the 
general practice e.g.  ‘Full blood count’, drug 
levels, ‘renal function’ etc. and more 
specialised tests e.g.  Protein electrophoresis 
genetic test panels etc. 
Microbiology All tests sent for organism culture and/or 
antibiotic sensitivity testing. Includes blood, 
swab, sputum, skin, faeces etc. Excludes 
urine microbiology 
Urine microbiology All urine specimens sent for organism 
culture, and or antibiotic sensitivity 
Urine biochemistry  All urine specimens sent for electrolyte 
analysis  
X-ray All types of x-ray imaging ordered, either 
through hospital or private service. (excludes 
CT, MRI or other radiology) 
Ultrasound  All types of ultrasound imaging ordered, 
either through hospital or private service.  
 
The simplification of the above classification was also due to the low numbers of more specific 
groupings; for example there were only two examples of genetic testing found, and so genetic 
testing was included in ‘blood tests’. 
Blood tests were not classified further by what parameters were being tested (e.g. full blood 
count, creatinine, electrolytes, CRP etc.) as it was difficult to know which were ‘routine’ tests 
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from the practitioner, and what was a test for a specific complaint/symptom. However as the 
majority of blood tests take approximately the same amount of time to process (in days), this 
grouping was deemed acceptable. Also, analysing wait time and harm by type of blood request 
was beyond the scope and resources of this study. 
Urine microbiology was recorded separately from other microbiology, as it was much more 
common. Separating out other microbiology would allow waiting times and harms from theses 
less common microbiology test to be analysed without them being lost amongst the large 
number of urine microbiology tests. 
As x-ray and ultrasound could be requested without radiology referral, these were categorised 
separately from radiology requests. They were also categorised as investigations and not as 
referrals. As they are different tests, often from different providers and different wait times, 
they were grouped separately from each other as well. 
2.4.1 Waiting times for investigations 
The data extracted only included the period in-between the practitioner requesting the test and 
the patient presenting for the test. The results were then backdated in the electronic system to 
the date when the patient presented for the test to the laboratory, and thus the time taken to 
do the laboratory testing itself was not included in the data collection. However, notes following 
each blood test were and these periods following the blood test were analysed to see if any 
harms occurred during this period, and recorded in the data table, using the same criteria as 
harm during waiting periods, described above in section 2.3. 
Lab results were automatically entered in the original electronic notes, with the date 
corresponding to the date that the lab received the request - i.e. when the lab received the 
sample from the patient. Data for processing times for most lab results were not available. 
However for some (e.g. cervical smears) waiting periods for reports were available and were 
recorded. In addition, periods between the lab sending the results and the practitioner 
reviewing the results were not available. 
Blood test data were only recorded if the referring practitioner was the GP or another clinician 
in the practice (i.e. blood tests ordered from outside the practice were not recorded). This was 
due to lack of notes about blood tests ordered by other specialists from outside of the practice, 
as reasons for request with resulting interpretation and treatment were not available, thus 




An aim of this project was to investigate if the harms found were preventable by being seen 
earlier. If a harm was present in a referral waiting period, the notes following the patient 
receiving specialist care were examined to determine the outcome of referral (what care was 
recommended and/or preformed).  The outcome was considered alongside the harm, and a 
judgement on preventability was made by the candidate.  This was recorded as either 
preventable (yes), non-preventable (no) or undeterminable (marked as “?”). However a large 
portion of harms were marked as undeterminable due to lack of detail in the notes of what 
treatment was initiated by specialists. This may have been due to the lack of information in the 
notes or the lack of clinical expertise of the candidate. Therefore, a judgement on preventability 
was found not to be reliable.  This aspect of the study was not further analysed and is not 
presented in the results section. For illustration of this, the percentages (marked as “yes”, “no” 
or “?”) are presented in Table 9 below. 
Table 9 Frequency and percentage of preventability of harms 
Preventability  Frequency Percentage of total harms 
(%) 
Undeterminable “?” 23 39.7 
Yes 21 36.2 
No 14 24.1 
Total 58 100.0 
 
2.6 Statistical analysis  
IBM SPSS 22 was the electronic statistics package used for all data analysis. 
The data were analysed in two stages. The initial stage was analysis per patient; gender and age 
distribution were obtained along with mean and median age. Additionally the patients who 
experienced harm were compared to patients who did not. Pearson Chi-square tests were 
performed to see if gender differed significantly between the two groups. ANOVA (one way 
analysis of variance) tests were performed for continuous variables -age and number of 
referrals per patient- to compare the groups. All comparisons were made separately for 
investigations and all referrals. Referrals to medical specialties and referrals to other specialties 
were combined for this analysis. 
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The second stage was the analysis of individual referrals. The mean patient age at referral, the 
median waiting timea at referral were calculated, in total and also by the three types of referral 
(investigation, referrals to medical specialties and referrals to other specialties). Referrals that 
resulted in harms were compared to those that did not, with ANOVA tests for age and waiting 
time. This was done separately for all three types of referral. The specialty that each referral 
was made to was analysed as was the mean waiting times for each specialty. 
The referrals resulting in harm were further analysed to provide proportion of the broad 
categories of which the harms were classified as, as well as the proportion of the severity of 
harms. 
 
                                                          




3.1 Patient characteristics  
Five years of complete general practice records for 201 patient notes containing a total of 5006 
entries marked as ‘consultation notes’ were completely analysed. There was a mean number of 
113.7 ‘consultation notes’ per patient record (standard deviation of 135.4). 
The demographics of these patients are explored below, and compared to national 
demographic data adapted from the 2006 NZ census, in order to gauge the generalisability of 
this study. The 2006 census data was used in preference to the 2013 census, as the notes from 
this study came from 2004 to 2007 - therefore the 2006 census is more applicable. 
Of the 201 patients, 105 were female (52.2%) and 96 male (47.7%). Figure 5 shows the age and 
sex profile of the study patients. The median age of all patients was 44 years and the median 
for males was 44 years and for females was 42. Table 10 shows how the age and sex of the study 
group compares with 2006 census data. The similarity between percentages of females and 
males in the study group and the New Zealand census indicates that neither males nor females 
are over represented in the study group.147 
Table 10 Demographics of study sample compared to New Zealand 2006 census data.147 
 2006 Census data147 
(n=4027947) 
Study sample (n = 201) 
Total median age (years) 35.9 44.0 
Female median age (years) 36.7 42.0 
Male median age (years) 35.1 44.0 
Proportion of females (%) 51.2 52.2 
Proportion of males (%) 48.8 47.7 
 
The census found an overall median age of 33.0 years and that females made up 51.2% of the 
total New Zealand population. The census also found a median age of 36.7 years for females 
and 35.1 years for males. The mean age for the study group was 41.3 years, (95% confidence 
interval (CI) of 38.02 to 44.6 years) and the mean age of the New Zealand census population in 
2006 was 36.3 years, which lies outside the 95% CI of the study group’s ages. This suggests that 
the study group is older than the New Zealand population. The distribution of ages in the study 
group is shown in Figure 5 below, separated by sex. 
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Figure 5 Age and sex distribution of study sample  
 
 
The outline of the data collection is shown in the flowchart Figure 6 below (from Chapter 2, with 




























Referrals = 29 
Harm present 
in gap 
Referrals = 9 
Harm present 
in gap 
Referrals = 45 
Harm present 
in gap 
Referrals = 4 
+ 
Figure 6 Flowchart showing study group and data selection – with results added 
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3.2 Patients who experienced harm 
Of all 201 patients, 38 (18.9%) experienced one or more harm related to referral while 163 
(81.1%) did not. The characteristics of these two groups are shown in Table 11 below and the 
age distributions are shown in Figure 7. The Pearson Chi-Square test for difference between the 
two patient groupsa  in the proportion of each group who were male and female was 0.601, (p-
value = 0.438). This result suggests that sex has no significant relationship with likelihood of 
harm in the gap between referral and receiving referred services. The details for the Chi-Square 
test are provided in Appendix C. 
Table 11 Demographics of patients who did and did not experience harm related to referral (to 
medical or other speciality) 
 Experienced harm 
(n=38) 




Mean age (years) 48.7 39.6 41.3 
Median age (years) 51.5 42.0 44.0 
Range (years) 78 (4-82) 92 (0-92) 92 (0-92) 
Proportion female 
(%) 
57.9 50.9 52.2 
Mean number of 
referrals per patient 
3.0 0.6 1.1 
 
                                                          
a Patients who experienced harm verses those who did not 
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An ANOVA test of the difference between the two study groups in age shows significance 
between age and harm related to referral (p = 0.031). This result indicates that age has a 
significant relationship with likelihood of harm in the gap between referral and receiving 
referred services. However the Eta Squared value of 0.023 indicated that the effect size was 
small. The ANOVA table is available in Appendix C. 
The mean number of referrals per patient was 1.1 over the five year period that the notes cover 
(a rate of 0.2 referrals per patient per year or 1 referral per year for every 5 patients). The mean 
number of referrals (excluding investigations) for those who did not experience harm was 0.6 
per patient, compared to 3.0 referrals per patient for those who did experience harm. When 
removing those who did not have any referrals (for whom it would not be possible to have harm 
related to referral) the mean is 1.7 for those with no harm. 




Figure 8 Referrals per patient – excluding investigations (bars are proportionally shaded to 
show those who incurred harm) 
 
 
An ANOVA test of the difference between the two study groupsa in number of referrals shows 
a significant difference (p-value = 0.01). The Eta squared value of 0.115 indicated that the effect 
size was small to medium. The ANOVA table is available in Appendix C. 
3.2.1 Patients who experienced harm related to investigations 
Similar results were obtained for patients who experienced harm related to referral for 
investigation; however, this is only for the first 101 patients for whom investigation data were 
recorded (this information was not collected for the next set of patients [101-201] and were not 
analysed). Overall 8 patients had harm related to investigation (7.9%) and 93 did not (92.1%). 
The characteristics of these groups are shown in Table 12. Figure 9 shows the age distribution 
                                                          




of the investigation group (n = 101), and demonstrates that all patents experiencing harm while 
waiting for referral for investigations were aged >40 years. 





Did not experience 
harm (n=93) 
Total (n=101) 
Mean age (years) 62.8 39.57 41.29 
Median age (years) 65.0 42.0 44.0 
Proportion female 
(%) 
62.5 50.5 51.5 
Mean number of 
investigations per 
patient 
17.6 3.9 5.0 
 
The mean number of investigations for those who experienced harm was 17.6 compared to 3.9 
for patients who did not experience harm. Figure 10 shows the distribution of number of 




Figure 9 Age distribution of patients with investigation data recorded (bars are shaded to show 




Figure 10 Investigations per patient who had investigation data recorded (bars are shaded to 
show patients experiencing harm) 
 
 
An ANOVA test of the difference between the two study groups in number of investigations 
shows a significant difference (p = 0.001). This result indicates that number of referrals has a 
significant relationship with likelihood of harm in the gap between referral and receiving 
referred services. The Eta squared value of 0.297 indicated that the effect size was large. The 
ANOVA table is available in Appendix C 
3.3 All referrals 
Most patients were not referred to specialist care; with 103 (51.2%) being referred for only 
investigations or having no referrals at all. 
The first 101 patients had information about both the specialist referrals made and also the 
investigations ordered (blood tests, microbiology, x-ray and ultrasound) by General 
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Practitioners. This enabled a comparison to be made between the referral patterns to specialists 
versus investigation referrals for this group. 
A total of 597 individual referrals/investigations were made over these 101 patients, with only 
16 patients having no referrals or investigations. Out of the 597 events, 505 were for 
investigations (82.4%), 78 were referrals to other medical specialties (12.7%) and 14 were 
referrals to other non-medical services (2.3%). 
The second set of patients (n = 100) had an additional 105 referrals to medical specialties and 
15 referrals to other specialties. However investigations (blood tests, microbiology, x-ray and 
ultrasound) were not recorded for patients. The total number of referrals for all 201 patients 
was 717. 
Excluding investigations, 212 referrals were recorded for all 201 patients. From the first 101 
patients an annual rate of referral per patient for investigation was calculated, and the same 
was done for referrals to medical specialties and non-medical specialties from the entire study 
group. This is shown in Table 13. 
Table 13 Rate of referrals by type of referral 
Referral type Number of 
referrals 
Number of patients Rate (per person per 
year) 
Investigation 505 101 1.00 
Referrals to specialties 212 201 0.21 
 Medical Specialty 183 201 0.18 
 Other specialty 29 201 0.03 
 
Of these referrals, 58 resulted in harm (9.72% of all referrals). 9 were from referrals for 
investigations (1.8% of all referrals for investigations), 45 from referrals to medical specialties 
(24.5% of all referrals to medical specialties) and 4 from referrals to other specialties (13.8% of 
all referrals to other specialties). 
3.4 Per referral 
Additionally, as some patients had more than one referral, the data were also analysed per 
referral event. There was a total of 717 individual referrals. These referrals were categorised 
into 505 investigation requests, 183 referrals to medical specialties, and 29 referrals to other 
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studies. The mean age of patients at the time of each referral is presented in Table 14 below. 
Figure 11 shows the age distribution of patients for each referral. 
Table 14 Mean ages for referral, by type of referral 




















52.0 20.5 50.2 53.8 0 86 
medical specialty 
(n=183) 
50.6 24.0 47.1 54.2 0 91 
other specialty 
(n=29) 
45.1 20.6 37.3 53.0 1 77 
Total 
(N=717) 





Figure 11 Patient age at referral (bars shaded to show patients experiencing harm) 
 
 
The ANOVA test of the difference between the two study groupsa in age at referral showed a 
non-significant difference (p = 0.407). This result indicates that age at referral had no significant 
relationship with likelihood of harm in the gap between referral and receiving referred services. 
The Eta Squared value of 0.001 supports this, showing no effect size. The ANOVA table is 
available in Appendix C 
When investigations were removed from the analysis, neither the age distribution shown in 
Figure 6 nor the ANOVA test were significantly changed (the p-value remained non-significant). 
These are both available in Appendix C. 
Waiting time data was available for 623 of the 717 referrals (86.9%); 488 of investigations 
(96.6% available), 124 of the referrals to medical specialties (69.7%) and 11 of the referrals to 
                                                          
a Patients who experienced harm verses those who did not 
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other specialties (37.9%). Excluded were referrals that were missing either dates when the 
referral was made, or dates when the patient were seen, therefore preventing a calculation of 
the waiting period. For the waiting periods that were available, the median wait times for each 
type of referral, as well as the quartiles are presented in Table 15 below (medians were used 
due to the skewed distribution of wait times). 
Table 15 Median waiting times (in days) by type of referral 












0.0 0.0 0.0 3.0 0 385 
medical specialty 
(n=124) 
43.0 6.3 43.0 122.5 0 600 
other specialty 
(n=11) 
20.0 16.0 20.0 88.0 6 106 
 
The data regarding waiting time are also presented in the Figure 12 below; additionally, the 
proportion in each interval that had harm in the waiting gap is shaded according to the key. 
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Figure 12 however, includes waiting times for investigations, which (as explained in the 
methods) predominantly had a recorded waiting time of 0 days. Therefore, to gain a better 
appreciation of the distribution of waiting times, Figure 13 excludes investigations. Again, the 
proportion in each interval that had harm in the waiting gap is shaded according to the key. 
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Figure 13 Waiting times for each referral, excluding investigations (bars are proportionally 
shaded to show those who incurred harm) 
 
 
To test if there was an association between harm and waiting period (days), an ANOVA test was 
conducted for each type of referral. This gave a p value and an Eta Squared value to judge 
likelihood of type I error and the size of effect respectively. 
ANOVA tests of the difference in waiting times between the two study groupsa were done for 
each type of referral. The p-value and Eta Squared values are summarised in Table 16. The full 
ANOVA tables are available in Appendix C. 
 
  
                                                          
a Patients who experienced harm verses those who did not 
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Table 16 Significance and size effect for relationship between harm and waiting times. Split by 
type of referral 
Type of referral p-value Eta Squared (effect size) 
Investigations 0.598 0.001 (none) 
To medical specialties 0.117 0.020 (small) 
To other specialties 0.063 0.334 (large) 
 
None of the ANOVA tests showed a significant difference with p-values > 0.05. These results 
indicated that waiting time has a no significant relationship with likelihood of harm in the gap 
between referral and receiving referred services.  The Eta Squared values support this for two 
of the referral types (investigations and medical specialties) with 0.01 and 0.20 indicating no 
effect size and a small effect size respectively. However the Eta Squared value of 0.334 for 
referrals to other specialties indicated a large effect size, suggesting a possible relationship.  
None of the ANOVA tests reach statistical significance (p < 0.05) however, the p value between 
waiting times for those who experience harm while waiting for referral to other specialties (p = 
0.063) is close to statistical significance. 
3.5 Types of harm 
Each harm was coded as described in the methods section; however due to large variety of 
harms, only the broad groupings used to describe each episode are presented here – however, 
the coded harms are available in Appendix B. Table 17 presents the number of harms in each 
broad category in decreasing magnitude; note that some harms were classified under multiple 
broad categories. 
Table 17 Proportions of broad categories of harms 
Broad Category of harm 
Number of referrals 
containing this as a 
harm 
Percentage of total harms 
(%) 
Continued symptoms 38 65.5 
Delay in subsequent management 14 24.1 
Deterioration of condition 14 24.1 
Financial cost to patient 7 12.1 
Anxiety/Mental harm 5 8.6 
Other 3 5.2 




Other included 3 other categories; “Decreased functioning”, “Hospital admission”, and 
“Carer/Family not coping” with one harm in each. 
The overall severity of each episode of harm is also presented in Table 18 below. 
Table 18 Frequency and percentage of severity of harms 
Severity of harm Frequency Percent (%) 
Mild 43 74.1 
Moderate 12 20.7 
Severe 3 5.2 
Total 58 100.0 
 
3.6 Referral by specialty 
The frequency of the twenty highest services (including investigations) referred to is shown in 
Table 19 below. Referrals to services that contributed less than one percent of all referrals (n < 
7) are compounded into the “other” category for brevity.  The full table showing frequency’s 
for all services is available in Appendix C. 
Table 19 shows the twenty referral services, along with the number of referrals with harm in 
the waiting gap. The services are ordered by decreasing percentage incurring harm.  
A Pearson Chi-square test was not possible due to n <5 in several categories. 
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Gynaecology 9 4 44.4 70.3 
Orthopaedics 29 12 41.4 154.8 
Cardiology 14 5 35.7 48.4 
Gastroenterology 17 5 29.4 120.0 
ENT 16 4 25.0 214.3 
Ophthalmology 8 2 25.0 65.0 
Psychological 
services 
12 3 25.0 35.3 
General surgery 19 3 15.8 111.0 
Ultrasound 10 1 10.0 105.7 
Neurology 10 1 10.0 55.0 
ED 21 1 4.8 0.0 
X-ray 43 2 4.7 9.3 
Cervical smear 43 1 2.3 5.3 
Microbiology 44 1 2.3 2.5 
Blood test 
(investigation) 
288 4 1.4 2.2 
Audiology 7 0 0.0 167.0 
Histology 16 0 0.0 3.4 
Physiotherapy 11 0 0.0 33.5 
Urine 
(investigation) 
49 0 0.0 1.4 
Other 51 9 17.6 n/a 




Following the data described in the previous chapter, this chapter examines the results and 
draws conclusions within the limitations of this study and with consideration to information 
described in the literature. 
As referral and harms is an under researched field, (even within the relatively new field of 
primary care safety research) this study adds new information to begin exploring harms related 
to waiting for referral. 
4.1 Summary of the main findings of this study 
The major findings, as related to the aims, are described below. 
Per patient, harm (as defined in this study) that was related to referral to medical and non-
medical specialties occurred to 38 (18.9%) of the patients during the 5 years covered by this 
study. 
Per patient, harm (as defined in this study) that was related to referral for investigation occurred 
to 8 (7.9%) of the patients during the 5 years covered by this study who had investigation data 
recorded (n=101). 
The rate of referrals to either medical or non-medical specialties was calculated at 0.21 per 
person per year. The rate of referral for investigations was calculated at 1.18 per person per 
year. Most referrals were for investigations (82.4%) then for specialty advice (12.7%) and finally, 
to non-medical specialties such as physiotherapy, dentistry, audiology etc. (2.3%). 
Per referral, over the 5 years covered by this study, harm occurred in 24.9% of referrals to 
medical specialties, 13.8% of referrals to other specialities, and 1.8% of referrals for 
investigations. Patients who had more referrals were more likely to experience harm in the gap 
between referral and receiving referred care. 
Referral waiting gaps are safe for most patients. Even if harm did occur, most harms (74.1%) 
were classified as minor harms. However moderate and severe harms did occur such as 
myocardial infarct while awaiting cardiology referral (severe), and inability to work due to 
osteoarthritis while waiting for orthopaedics referral (moderate). Most harms were broadly 
grouped as “Continued Symptoms” (65.5%). 
No statistically significant relationship between the length of waiting times and incidence of 
harm was found. There also was no difference between males and females in the likelihood of 
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their experiencing harm, but patients who experienced harm were older than those who did 
not. 
No data collected in this study measures the duration of harm experienced by patients; no data 
of the length of each harm was collected during analysis of the notes nor was duration a 
consideration when grading severity or type of harm. This study is limited to incidence rather 
than prevalence of harm.   
4.2 Discussion of findings 
The findings of this study, while outlined above are presented in this section. Additionally, 
certain choices of methodology do affect the interpretation of the results and these are 
discussed. 
The demographics of this study group reflect how populations enrolled in general practices 
differ from the wider New Zealand population. The significant difference between the age of 
the study group and census data suggests that the study group is older than the New Zealand 
population, generally. This is expected, as other studies have found that patients enrolled in 
General Practices in New Zealand tend to be older than the wider population.148 When 
separated by sex, males in this study have a higher mean age (44 years) than females (42 years), 
which is not consistent with the New Zealand Census data – however when shown on a 
distribution (Figure 5) this is explained by the comparative lack of younger (15-35) males, who 
are under-enrolled in practices.148,149 
4.2.1 Overall rate of harm 
The rate of harm related to referral per patient of 18.9% is higher than the rate found in early 
hospital studies.5,6 This is most likely due to use of the broader definition of harm suggested by 
Runciman.32 Use of this definition included harms that may not have been classified under the 
definition of ‘adverse events’a used in the hospital based studies (section 1.4.1), and therefore 
may have been excluded.  
The broader definition used in this study may reflect patient’s experiences better, as it includes 
all harms, but does limit comparability of the present study to the previous literature. 
The broad definition of harm is moderated by an inherent clinician threshold in this study. That 
is, as the study data are consultation records written (mainly) by doctors, they are likely to have 
                                                          
a “an injury caused by medical management (rather than the disease process) that resulted in either a 
prolonged hospital stay or disability at discharge”.6  
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recorded only issues that they considered important: they may not have bothered to record 
issues they considered minor, or expected, among complaints brought to them by patients. 
Overall this should limit records of harms to those reaching a certain threshold for clinicians to 
include an account of harm the notes. This should limit some over reporting of ‘lesser’ harms, 
yet still include ‘greater’ harms.  
The only published general practice records review which also used a similarly broad definition 
to the present study was by Gaal et al.92  There the authors found 186 out of 1000 patient 
records (18.6%) contained any type of harm, not just related to referral. However Gaal et al 
recorded only preventable harms; the present study records all harms regardless of 
preventability. This may account for the similar percentage of patients with harm, even though 
Gaal et al examined notes for all types of harms compared to the present study, which looks 
only for harms related to referral gaps. 
The largest primary care reporting study by Bhasale et al found that patients who were female 
and older were overrepresented in harm reports.86 In the present study, patients who 
experienced harm were older than those who did not, yet there was no relationship between 
sex and harm. However the calculated effect size of age was small, advising that age is not a 
good predictor for likelihood of harm in the waiting gap studied. This suggests that harms 
related to referral effects all patients of either gender and of any age (although older patients 
slightly more). This can be seen in Figure 7, with some patients of almost all age groups 
experiencing harm related to referral (green shaded portions of bars). 
When examining the data by referral type rather than by patient, the proportion of referrals 
showed that most of referrals were for investigations (82.4%), while a smaller proportion were 
for referrals to medical specialties (12.7%), and fewer again for referrals to non-medical 
specialties (2.3%). For referrals to specialties (i.e. the latter two combined), this gives an overall 
rate of referral of 0.21 referrals per patient per year, which when converted to a rate per 
consultationa is 4.2% of consultations. This fits with the finding by O’Donnell that rates in the 
UK vary from 1.5% to 19.1% of consultations resulting in referral.101 The only comparable 
research in New Zealand reported a rate of referral to hospital specialties of 0.27 referrals per 
patient per year.104 However, as the present study is reliant on practitioners entering the 
referrals into the notes, referrals may have been missed, likely leading to underreporting of the 
                                                          
a 5003 consultations with 212 referrals (excluding investigations), approximately 4.2% of consultations 
resulted in referral. 
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true referral rate. This would still fit with the literature, which shows large variations in rate of 
referral.101,103,150,151 
Out of 717 referrals, in 58 of these, the patients referred experienced harm in the waiting gap 
(8.1%). When split by type of referral, out of 183 referrals to medical specialties, 45 had harm 
present in the waiting gap (24.5%). This was a high rate of harm (alongside the rate of 13.7% of 
referrals to other specialities), when compared to previous patient safety studies.5,6,92 Again, 
the most likely cause of this discrepancy may be the use of the broad definition used in the 
present study. There is no other study yet published that the candidate could find of referral 
harm either using a broad or narrow definition of harm, and so the degree of over estimation 
in this study that has been caused by a broad definition it is yet undetermined. 
4.2.2 Predictors of harm 
Further examining referrals, the mean age of patients at the time their referral was 51.4 years 
(95% CI 49.8 – 53.0), with a large range of 0 to 91 years, indicating referrals happen at all ages. 
However, age at referral was not statistically related to incidence of harm in the waiting gap. 
This conflicts with the finding that older patients were more likely to have harm in the gap 
(section 3.2) and is likely due to examination of a relatively small set of patient records and a 
Type I error (a false positive error) in the testing of statistical significance. 
Additionally, length of the waiting gap (days) had no statistically significant relationship to 
incidence of harm in the waiting period. This means that how long a patient waited between 
referral and receiving services did not effect if they experienced a harm in the waiting gap. This 
however is not related to the length of harm experienced, as this information was not collected 
in this study.  
The p-values for harm and waiting times in Table 16 show that, for referrals to medical 
specialties and other specialties (p-values 0.117 and 0.063 respectively), while not significant in 
this study, were approaching significance and perhaps a larger study would detect a statistically 
significant result. However, the effect size for referral to medical specialties was small (Eta 
Squared = 0.020) suggesting that even if it were statistically significant it is not a strong predictor 
of harm. The effect size for referral to non-medical specialties was large (Eta Squared = 0.334) 
suggesting that harm while waiting for referrals to non-medical specialties may be affected by 
waiting time, unlike referrals to medical specialties. However with a small number of referrals 
to non-medical specialties (29) and only a small number of these having waiting time 
information (11 i.e. 37.9%) this conclusion is tentative.  
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4.2.3 Types of harm 
When examining the type of harms present, 38 of the harms (65.5%) were grouped under 
continued symptoms. Continued symptoms, (i.e. the same or similar symptoms to those 
presented with when the referral was made) would not have been classified as a harm in 
previous studies, but represents the majority of harms in the present study due to the definition 
of harm used which includes ‘disease’ within harma (as discussed previously). Whether 
continued experience of ill health constitutes a ‘harm’ in a clinical use of the term is debatable, 
however it does indicate that for a large proportion of referrals patients re-present to general 
practice - with symptoms related to their referral, and that they may have been resolved or 
better managed with earlier receipt of referred services. 
The next largest categories of harm were “delay in subsequent management” and 
“deterioration of condition” each with 14 episodes of harm (24.1% of harms) including these as 
a classification (episodes of harm may have had more than one broad classification). These 
delays in care may be more likely to be classified traditionally as harms in other studies.85,88,92 
“Delay in subsequent management” signals a patient receiving sub-optimal care as a direct 
result of waiting for referral. This circumstance is likely to have been under reported in this 
study, due to letters from specialists to general practitioners not being included in the data.  
“Deterioration of condition” included harms classified as ‘severe’ including a myocardial 
infarction and an episode of self-harm while waiting for cardiology and psychological services 
referral respectively. Harms grouped under “deterioration of condition” indicate harm where 
patients have re-presented with worse symptoms. While similar to “continued symptoms”, 
these harms represent patients with conditions which have gotten worse after being referred, 
and additional suffering for patients, which may have been prevented by being seen earlier. 
Additionally referral may have had to be expedited, or additional ‘stop-gap’ treatment offered. 
This is also likely to have been underreported in this study, again, due to unavailability of letters.  
The other broad categories of harm include “financial cost”, “Anxiety/mental harm” and 
“other”.  These categories have been included in previous studies.69,85,92 Seven harms (12.1% of 
harms) were grouped under “financial cost”. Patients experiencing financial harm either lost 
income or had to pay for appointments or treatments they may not have had to if they had 
been seen by the referred specialty earlier. To these patients the financial cost was significant 
enough to discuss it with their GP and for it to be recorded in the notes.  
                                                          
a “Disease: A physiological or psychological dysfunction”.32  
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A qualitative study by Preston et al showed that patient anxiety and concern was a common 
theme amongst patients waiting for referral, and was included in the definition used in this 
study.130 With only 5 harms being categorised under this (8.6% of all harms) this is surprisingly 
low, considering how common a theme this was amongst participants in the study by Preston 
et al. However this discrepancy may be due to the clinician threshold for recording this type of 
harm in the notes and possibly patient reluctance to discuss their anxiety during a consultation. 
The other category included 3 harms; “decreased functioning” “hospital admission”, and 
“carer/family not coping” with one episode grouped under each category. These, therefore, are 
less common harms and with the small numbers in this study few conclusions can be drawn. 
However, hospital admissions due to waiting for referral are a potentially important area for 
investigation for future larger studies, as these may result in important patient and healthcare 
costs. 
The severity of harms found in this study is mainly minor (74.1% of all harms). This corresponds 
to previous studies, with Gaal et al finding most harms in primary care did not affect patients, 
and New Zealand hospital studies finding 61.6% of adverse events caused minimal disability.10,92 
This implies that for most referrals the waiting period is safe (“freedom from accidental injury”) 
in New Zealand, as of the harms that do happen (in up to 24.1% of referrals, depending on the 
type of referral) the majority are minor causing no or temporary disability (the definition of 
‘minor’ used in this study). However a small number of moderate and severe harms were found 
in this study (12 and 3 respectively) confirming that, while not common, referral waiting periods 
can contain greater harm and are not completely free of risk of injury to patients. 
While data regarding preventability was collected (if being seen earlier would have prevented 
the harm that was present in the waiting gap), for 23 of the harms (39.7% of all harms) this 
could not be determined, and so was recorded as unknown.  This was a larger proportion than 
either preventable harms (21 i.e. 36.2% of all harms) or non-preventable (14 i.e. 24.1% of all 
harms) and so no further analysis was performed. Any conclusion drawn from this analysis 
would be almost meaningless with such a large level of uncertainty regarding preventability. 
4.2.4 Specialties referred to 
Table 19 shows referrals by specialty, ordered by descending proportions with harm in the 
waiting gap. This suggests that referrals to some specialties may be more likely to be associated 
with patient harm in the waiting gap. The three speciality referrals with the greatest proportion 
of harm were Gynaecology (44.4%), Orthopaedics (41.4%) and Cardiology (35.7%). While the 
small numbers in this study (9, 29 and 14 referrals respectively) prevent firm indication that 
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these are the services that are more likely to have harm in the waiting gap, it does suggest that 
these services may require more attention in future studies. 
Additionally data were collected about the mean waiting times for each service (available in 
Table 19 as well as in Appendix C), with ENT, Sleep Laboratory and Orthopaedics having the 
longest wait times all were over four months, the current New Zealand Ministry of Health target 
- although this was implemented several years after the period covered by the patient notes in 
this study. Waiting times in this study are similar to waiting times reported in overseas literature 
on waiting times, which show services having wait times over 120 days.116 However, there is 
some inconsistency between wait times for individual services internationally and in this study; 
for example, a waiting time for general surgery of 56 days in an 2003 OECD report, compared 
to 110.9 days in the present study.117 This is expected as international studies have found large 
variation between services and between countries. However, again with the small numbers for 
some services in this study, compounded with some uncertainty of the waiting periods (due to 
non-inclusion of letters in the data), means that this study is not definitive for waiting periods 
in New Zealand. 
4.3 Limitations 
This study is affected by several limitations, some that have already been discussed above in 
relation to specific findings. This section explores these and other limitations. 
The small study group of 201 patients is a limitation of this study. The number of consultations 
(5,003) is reasonable in comparison to the literature; Gaal et al reviewed 8,401 consultation 
records in the only primary care records review study to date.92 This number of consultations 
was achieved in the present study as each individual record covered a five year period, rather 
than the notes in Gaal et al covering one year. While giving a more longitudinal view for each 
patient, fewer individual patients were reviewed, reducing the inter-patient variety and 
therefore providing a narrower range of referrals and also possibly a narrower range of harms 
than a shorter study with more patients might have achieved.  
Also, no sample size was calculated due to time constraints as outlined in section 2.2, however, 
this means it is unknown if the sample size was sufficient to determine significant differences 
between different subsets of patients. This is a significant flaw in the method, as there was no 
clear end point for data collection, instead utilising arbitrary targets. 
The sampling of this study is a potential limitation. The notes were sequentially analysed, relying 
on the randomisation of the order of the HRC feasibility study records. It was unclear what 
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randomisation method was used in the feasibility study, and while unlikely, this may mean that 
the patients in the current study were a biased sample an unknown way. 
Additionally, an initial subset of 101 patients had information collected regarding investigations 
collected, making the sample size for investigations smaller again. Also, collecting additional 
data for the first 101 patients but not the second 100 patients means that these two groups had 
slightly different methods of data collection applied. However, with non-investigation referrals 
a significant effort was made to keep the methods of reviewing the records the same to 
minimise any effect this may have had. 
Another limitation in this study is the use of the records review method. Healthcare records 
were not written for research purposes, and so are not written with the consistent, 
standardised methodological approach that primary research data would normally 
achieve.152,153 Further, there is variability between clinicians and so there may be little 
consistency between sets of records of different patients with different doctors. However, the 
study data does reflect real world conditions, where some clinicians may be more likely to 
regard an event as a clinically significant harm and record it in the notes while other clinicians 
may not. This means that this study determined the presence of harm related to referral in the 
notes rather than actual presence of harm. 
The format of the extracted data is a significant limitation to this study. The extracted data did 
not include referral letters to specialists nor did it contain letters back from specialities to the 
General Practitioners. These letters were removed to successfully preserve patient anonymity 
but their removal also constrained precision in determining when referrals were made and 
when patients were seen by specialties. Some information could be gathered from manual 
entries in the records by practitioners. This likely led to underestimation of referral events and 
over estimation of some waiting periods. 
In addition, in the data extraction process (which occurred before the current study began) the 
consultation records were truncated at 256 characters, which led to some records being 
incomplete.  Again, as referral plans were often described at the end of records, this would 
result in the underreporting of referrals. However, this probably was not a major consideration 
because the referral rate per person per year in this study was not dissimilar to other reports of 
referral rates. Records of harms related to waiting for referral may also have been at the end of 
consultation records, and therefore harms may be underreported in this study. 
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The notes covered the period of 2003 – 2007, and so the data does not reflect recent change in 
the New Zealand Healthcare system; such as shorter Ministry of Health waiting time targets or 
DHB implementation of referral guidelines (or ‘pathways’).113,154,155 These changes may limit the 
applicability of the current study to current practice – both shorter waiting times and guidelines 
to ensure high risk patients are seen earlier may reduce the harm in the current period 
compared to the period covered in the present study. Additionally, no ethnicity or 
socioeconomic data were available for the patients in this study – so no exploration could be 
preformed of the relationship between these demographic characteristics and harm in the 
waiting gap. 
The above issues with data were not correctable within the short 12 month period of this 
BMedSc(hons) project. The issues with the study database were known at the start of the 
present study, and in order to fit within the 12 month timeframe a decision was made to 
continue using these records with all their limitations, rather than re-extract data. A new data 
collection is currently being made from randomly selected New Zealand general practices, but 
these data will not be available for analysis until 2017. General practice consultation data are 
not included in any of the Ministry of Health’s publicly available data collections. If general 
practice data are needed for research they have to be compiled separately and with external 
funding and resources, so existing general practice consultation databases are rare and 
therefore often reused, as in the current project.   
The limitation of only having one reviewer of records (the candidate) is that any bias is 
unchallenged. Without use of multiple reviewers, a certain type of harm may go under reported 
or over reported as there is potentially a subjective element in interpreting the notes and 
classifying harms. If present, this is unlikely to have been corrected without the use of another 
reviewer. On the other hand, there will be greater consistency in data interpretation with one 
reviewer than if more had been involved. 
4.4 Strengths 
There are several strengths of this study which support the findings and conclusions drawn. 
Five years of records were reviewed, which is more than previous studies that usually cover a 
single year. For this project that identified waiting gaps over four months, a longer period of 
notes is an advantage as the study is more likely to cover the entire period of a waiting gap as 
well as examine consequences following receiving specialist services. 
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A strength of this study is that records were gathered from various practices and practitioners 
giving a wider variety of notes and clinician recording styles as well as reducing the effect of a 
bias held by a single practitioner. 
The use of only one reviewer, although introduces bias (as discussed above) also ensures 
consistency of review of records, and prevents inter-reviewer discrepancies. 
4.5 Implications 
This study is the first records review study of harms during referral waiting gaps that I could 
identify in New Zealand or from the international literature.  
The findings of this study do support the notion that harms to patients happen during referral 
waiting periods, and that additional care may be required during these gaps. This study found 
no strong predictors of harm during the waiting gap, and so, until further information is 
available, all referrals hold potential for harm.  
Because of the small size of the study, the limitations outlined above, and the lack of other 
studies to support the findings, there should be some caution in interpreting the findings of this 
study to make changes in clinical practice. The most that can be applied is, for now, that 
clinicians should be aware that harms happen in waiting gaps and be prepared to care for the 
patients for whom this occurs. 
The most significant implications of this study are for subsequent research. The present study 
is an exploratory study and hence lays the groundwork for future research in this area. This 
study has determined an overall rate of harm, the variety of harm and suggested that referral 
to some specialties may have higher rates of harm than others. These are all areas for potential 
future study. 
Future research should address some of the design limitations of this study and further explore 
and corroborate or refute some of the findings – especially the finding that length of waiting 
times has little relationship to incidence of harm. Additionally, as this study was limited by 
having only clinician notes to determine harm, perhaps a future study may include more of the 
patient viewpoint by incorporating interviews and/or surveys. Finally, a study using a more 
recent period of notes or a prospective study would have more relevance to current healthcare 
in New Zealand and be able to develop firmer recommendations to improve current health care. 
Overall this study, while limited and small in scope, is an important beginning to exploring harms 
in the interface between primary and secondary care. The findings confirm that harms do occur 
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Appendix B – Additional method information 
HRC Feasibility study 
Coding information 
Top code Description 
1 Access/Communication 
1.1 Referral harm 
1.1.1 Delay in referral from GP 
1.1.2 Delay in referral processing at hospital 
1.2 Delay in hospital admission 
1.2.1 No bed available 
1.3 Delay in receiving treatment 
1.3.1 Delay in procedure 
1.3.2 Delay in receiving prescription 
1.4 Miscommunication 
1.4.1 Miscommunication about procedure 
1.4.2 Miscommunication about medication 
2 Investigation/Diagnostic harm 
2.1 Associated with diagnostic investigation 
2.2 Associated with results 
2.3 Associated with diagnosis 
2.3.1 Delayed diagnosis 
3 Treatment harm 
3.1 Drug harm 
3.1.1 Drug interaction 
3.1.2 Medication Change 
3.1.3 Drug not given or changed in a timely way 
3.1.4 Polypharmacy 
3.1.5 Drug information 
3.1.6 Drug given in association with surgery 
3.2 Surgical harm 
3.3 Liquid nitrogen 
3.4 Dressings 
3.5 Other 
3.5.1 Urinary catheter 
3.5.1.1 Blocked catheter 
4 Economic harm 
4.1. Repeat visit 
4.2. Further medication required 
4.3. Time off work 
4.3.1.  For self 
4.3.2.  To care for dependant/spouse/parent 
4.4. Further investigations required 
4.5. Private care (patient chose to pay to go privately because of 
  waiting times) 
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Top code Description 
4.6. Hospital admission 
4.6.1.    ED visit 





Patient / symptoms 
 
Top code Description 




















1.10 Cognitive impairment 
2 Pain 
2.1 Musculoskeletal  
2.2 Headache 
2.3 Tongue pain 
2.4 Urinary retention 




3.4 Aggravation of respiratory condition 
4 Rash 
4.1 Photosensitivity rash 
4.2 Lichen planus 
4.2.1 Oral lichen planus 
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Top code Description 
5 Bleeding  




6.1 Skin infection 
6.2 Persistent infection 
6.3 Thrush 





7.4 Delayed healing 
8 Oedema 
8.1  Peripheral oedema 
9 Weakness 
9.1 Atrophy 
9.2 Muscle stiffness 
9.3 Osteoporosis 
9.4 Malabsorption 
9.4.1 Iron deficiency 




10.4 Low WCC 
10.5 Abnormal liver function result 
10.6 Reduced renal function 
10.7 Raised CK 
11 Sensory changes 
11.1   Peripheral neuropathy 
11.2 Tingling 
11.3 Hearing loss 
11.3.1 Reversible hearing loss 
11.4 Sensation of dryness 
11.5 Dry Mouth 
12 Ulcer 
12.1   Mouth ulcer 
12.2 Corneal ulcer 
13 Fissure 
13.1 Anal fissure 
14 Infarction 




15.1 Bowel cancer 
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Top code Description 
16 Fracture 
16.1 Metatarsal fracture 
17 Mental Harm 
17.1 Upset 











































Method of prevention Notes 
47 80 M 28 79 Blood test 1 20/02/2007 28/03/2007 36 N     To wait 1 month 
47 80 M 29 80 Orthopaedics 2 25/05/2007 ? #VALUE! ?     Refer to fowler - not sure if seen 
48 4 F 1 4 Dentistry 3 27/06/2006 19/09/2006 84 Y 
Continued 
symptoms 
Mild Y seen earlier 
dental abscess, referred to dental unit - unsure if original referral by Dr or directly from dental 
unit 
49 11 F 1 6 
Urine - 
microbiology 
1 15/01/2003 17/01/2003 2 N      
49 11 F 2 6 Paediatrics 2 22/01/2003 12/02/2003 21 N     
Referred to private, then bounded to public system as no private paeds service. Appt cancelled 
on 12/02, probably due to symptoms resolving 
49 11 F 3 8 Blood test 1 22/04/2004 22/04/2004 0 N      
49 11 F 4 8 X-ray 1 22/04/2004 22/04/2004 0 N      
49 11 F 5 8 Ultrasound 1 22/04/2004 22/04/2004 0 N      
49 11 F 6 8 Blood test 1 15/10/2004 15/10/2004 0 N      
49 11 F 7 8 
Urine - 
microbiology 
1 15/10/2004 15/10/2004 0 N      





Mild ? review results earlier Talked to patient 06/06/06 - when mother called re tests… 
50 67 M 1 66 Blood test 1 18/07/2007 19/07/2007 1 N      




Started on medication? 
Probably not preventable 
MI following episodes of chest pain from 18/07/07 
50 67 M 3 66 
Domestic 
Assistance 




Appendix C – Additional results 
The following are additional raw outputs from IBM SPSS 22 that were not included in Chapter 
3, and are included here for reference. As a result all following results are unformatted and 
tables are untitled. 
Statistic calculations 
Pearson Chi-Square test for gender and harm related to referral to specialist (medical or other) 
 
ANOVA calculations 
ANOVA – Age vs Harm 





Square F Sig. 
Age 2007 * Had 
harm related to 




2559.532 1 2559.532 4.700 .031 
Within Groups 108366.149 199 544.554   
Total 110925.682 200    
 
The measure of association is shown below. 
 Eta Eta Squared 
Age 2007 * Had harm related 
to referral (2 or 3) 
.152 .023 
 







Pearson Chi-Square .601a 1 .438   
Continuity Correctionb .354 1 .552   
Likelihood Ratio .603 1 .437   
Fisher's Exact Test    .475 .277 
N of Valid Cases 201     
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 18.15. 
b. Computed only for a 2x2 table 
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ANOVA – Number of referrals vs Harm 
ANOVA calculation for correlation between number of referrals and harm related to referral 
 
Had harm related to referral 
(2 or 3) Mean N Std. Deviation 
No 1.68 60 1.396 
Yes 2.95 38 2.155 







Square F Sig. 
Number of referrals 
(2or3) * Had harm 





37.173 1 37.173 12.439 .001 
Within Groups 286.878 96 2.988   
Total 324.051 97    
 
The measure of association is shown below. 
 
 Eta Eta Squared 
Number of referrals (2or3) * 
Had harm related to referral 
(2 or 3) 
.339 .115 
 
ANOVA – Investigation, number of investigations per patient vs harm 
 
Had harm related to 
investigation Mean N Std. Deviation 
No 3.94 93 5.239 
Yes 17.63 8 10.281 







Square F Sig. 
Number of 




1380.472 1 1380.472 41.852 .000 
Within Groups 3265.488 99 32.985   
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harm related to 
investigation 
Total 
4645.960 100    
 
The measure of association is shown below. 
 
 Eta Eta Squared 
Number of investigations * 




ANOVA – Age at referral vs harm 
ANOVA calculation for correlation between age at referral (years) and if harm was present in 
the waiting gap. 
 
Harm present in gap Mean N Std. Deviation 
N 51.59 659 21.492 
Y 49.02 58 21.162 







Square F Sig. 
Age at referral * 




353.347 1 353.347 .767 .381 
Within Groups 329452.179 715 460.772   
Total 329805.526 716    
 
 
 Eta Eta Squared 
Age at referral * Harm 
present in gap 
.033 .001 
 








Harm present in gap Mean N Std. Deviation 
N 50.60 163 24.105 
Y 47.49 49 21.692 
Total 49.88 212 23.556 
 
ANOVA calculation for correlation between age at referral (years) and if harm was present in 









Square F Sig. 
Age at referral * 




364.727 1 364.727 .656 .419 
Within Groups 116717.325 210 555.797   
Total 117082.052 211    
 
The measure of association is shown below. 
 Eta Eta Squared 
Age at referral * Harm 





ANOVA – Investigation, waiting time vs harm 
 
Harm present in gap Mean N Std. Deviation 
Std. Error of 
Mean 
N 5.367 479 25.6135 1.1703 
Y 9.889 9 13.2518 4.4173 
Total 5.451 488 25.4398 1.1516 
 
ANOVA calculation for correlation between waiting time length (days) for investigations and if 






Square F Sig. 
Waiting time (Days) 





180.599 1 180.599 .279 .598 
Within Groups 314998.221 486 648.144   
Total 315178.820 487    
 
The measure of association is shown below. 
 Eta Eta Squared 
Waiting time (Days) * Harm 






ANOVA – Referral to medical specialties, waiting time vs harm 
 
Harm present in gap Mean N Std. Deviation 
N 79.656 93 119.8103 
Y 117.742 31 104.7530 
Total 89.177 124 116.9927 
 
ANOVA calculation for correlation between waiting time length (days) for referrals to medical 






Square F Sig. 
Waiting time (Days) 





33725.172 1 33725.172 2.494 .117 
Within Groups 1649810.925 122 13523.040   
Total 1683536.097 123    
 
The measure of association is shown below. 
 
 Eta Eta Squared 
Waiting time (Days) * Harm 
present in gap 
.142 .020 
 
ANOVA – Referral to other specialties, waiting time vs harm 
Harm present in gap Mean N Std. Deviation 
N 37.222 9 36.2380 
Y 94.500 2 14.8492 
Total 47.636 11 40.1180 
 
ANOVA calculation for correlation between waiting time length (days) for referrals to other 












Waiting time (Days) 





5368.490 1 5368.490 
 
4.505 .063 
Within Groups 10726.056 9 1191.784    
Total 16094.545 10     
 
The measure of association is shown below. 
 
 Eta Eta Squared 
Waiting time (Days) * Harm 







Referrals to all specialties 
 Frequency Percent Valid Percent Cumulative 
Percent Blood test 288 40.2 40.2 40.2 
Urine 49 6.8 6.8 47.0 
Microbiology 44 6.1 6.1 53.1 
Cervical smear 43 6.0 6.0 59.1 
X-ray 43 6.0 6.0 65.1 
Orthopaedics 29 4.0 4.0 69.2 
ED 21 2.9 2.9 72.1 
General surgery 19 2.6 2.6 74.8 
Gastroenterology 17 2.4 2.4 77.1 
ENT 16 2.2 2.2 79.4 
Histology 16 2.2 2.2 81.6 
Cardiology 14 2.0 2.0 83.5 
Psychological services 12 1.7 1.7 85.2 
Physiotherapy 11 1.5 1.5 86.8 
Neurology 10 1.4 1.4 88.1 
Ultrasound 10 1.4 1.4 89.5 
Gynaecology 9 1.3 1.3 90.8 
Ophthalmology 8 1.1 1.1 91.9 
Audiology 7 1.0 1.0 92.9 
Radiology 7 1.0 1.0 93.9 
Geriatrics 6 .8 .8 94.7 
Paediatrics 5 .7 .7 95.4 
Vascular 5 .7 .7 96.1 
Rheumatology 4 .6 .6 96.7 
Urology 4 .6 .6 97.2 
Dentistry 2 .3 .3 97.5 
Dietician 2 .3 .3 97.8 
Domestic Assistance 2 .3 .3 98.0 
Pain Clinic 2 .3 .3 98.3 
Podiatry 2 .3 .3 98.6 
Dermatology 1 .1 .1 98.7 
GP 1 .1 .1 98.9 
Midwife 1 .1 .1 99.0 
Nephrology 1 .1 .1 99.2 
Neurosurgery 1 .1 .1 99.3 
Oncology 1 .1 .1 99.4 
Plastics 1 .1 .1 99.6 
Podiatrist 1 .1 .1 99.7 
Rehabilitation 1 .1 .1 99.9 
Sleep Lab 1 .1 .1 100.0 
Total 717 100.0 100.0  
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Waiting time per service (days) 
Service referred to Mean (days) N Std Deviation Std. Error of mean 
ENT 214.333 9 186.4511 62.1504 
Sleep Lab 192.000 1   
Orthopaedics 154.778 18 125.2318 29.5174 
Audiology 167.000 3 198.6530 114.6923 
Gastroenterology 120.000 13 158.6942 44.0138 
Neurosurgery 115.000 1   
General surgery 110.938 16 104.9759 26.2440 
Pain Clinic 110.000 1   
Ultrasound 105.625 8 151.1990 53.4569 
Rehabilitation 105.000 1   
Oncology 97.000 1   
Plastics 91.000 1   
Urology 86.000 2 111.7229 79.0000 
Dentistry 84.000 1   
Gynaecology 70.286 7 44.5672 16.8448 
Ophthalmology 65.000 5 82.5984 36.9391 
Vascular 56.500 2 27.5772 19.5000 
Neurology 55.000 6 57.8481 23.6164 
Rheumatology 52.667 3 44.4560 25.6667 
Cardiology 48.375 8 51.0348 18.0435 
Radiology 39.000 5 26.4764 11.8406 
Geriatrics 37.667 3 64.3765 37.1678 
Psychological services 35.333 3 46.3069 26.7353 
Dermatology 35.000 1   
Physiotherapy 33.500 2 23.3345 16.5000 
Dietician 27.500 2 10.6066 7.5000 
GP 17.000 1   
Podiatry 16.000 1   
Podiatrist 15.000 1   
X-ray 9.308 39 18.6818 2.9915 
Paediatrics 7.000 3 12.1244 7.0000 
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Service referred to Mean (days) N Std Deviation Std. Error of mean 
Cervical smear 5.275 40 5.4865 .8675 
Histology 3.375 16 9.8311 2.4578 
Microbiology 2.545 44 10.6257 1.6019 
Blood test 2.196 285 5.6888 .3370 
Urine 1.408 49 6.3177 .9025 
ED 0.000 21 0.0000 0.0000 
Total 22.860 623 66.0656 2.6469 
 
 
